non redundant human proteome database Search Results


98
Bio-Rad non reducing sds buffer
Non Reducing Sds Buffer, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/SDS/pmc05574500-40-24-46
Average 98 stars, based on 1 article reviews
non reducing sds buffer - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

99
Thermo Fisher gene exp gapdh hs99999905 m1
p38 MAPK subtype expression in human CF. (A) Relative mRNA levels for p38 subtypes in CF from 8 different patients quantified using real-time RT-PCR. Data are expressed as percentage of <t>GAPDH</t> mRNA levels (2 −ΔCT × 100) and depicted as a box and whisker plot (box defines 25th–75th interquartile range, whiskers depict full range, and horizontal line is median). (B) Whole cell homogenates of CF (5 patients) or human saphenous vein endothelial cells (2 patients) were immunoblotted for expression of p38 subtypes. Blot reprobed with β-actin antibody to confirm equal loading.
Gene Exp Gapdh Hs99999905 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/Gene+Exp%2E+GAPDH%2C+Hs99999905_m1/pmc03573232-36-11--1
Average 99 stars, based on 1 article reviews
gene exp gapdh hs99999905 m1 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
ATCC non small cell lung cancer cell line
p38 MAPK subtype expression in human CF. (A) Relative mRNA levels for p38 subtypes in CF from 8 different patients quantified using real-time RT-PCR. Data are expressed as percentage of <t>GAPDH</t> mRNA levels (2 −ΔCT × 100) and depicted as a box and whisker plot (box defines 25th–75th interquartile range, whiskers depict full range, and horizontal line is median). (B) Whole cell homogenates of CF (5 patients) or human saphenous vein endothelial cells (2 patients) were immunoblotted for expression of p38 subtypes. Blot reprobed with β-actin antibody to confirm equal loading.
Non Small Cell Lung Cancer Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/NCI-H23/pmc05342372-129-3-12
Average 96 stars, based on 1 article reviews
non small cell lung cancer cell line - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology hairpin rna shrna
p38 MAPK subtype expression in human CF. (A) Relative mRNA levels for p38 subtypes in CF from 8 different patients quantified using real-time RT-PCR. Data are expressed as percentage of <t>GAPDH</t> mRNA levels (2 −ΔCT × 100) and depicted as a box and whisker plot (box defines 25th–75th interquartile range, whiskers depict full range, and horizontal line is median). (B) Whole cell homogenates of CF (5 patients) or human saphenous vein endothelial cells (2 patients) were immunoblotted for expression of p38 subtypes. Blot reprobed with β-actin antibody to confirm equal loading.
Hairpin Rna Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/USP14+siRNA/pm29326710-50-18-60
Average 93 stars, based on 1 article reviews
hairpin rna shrna - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology non incubated lc3c blots
Intracellular P. gingivalis ( P. g ) Significantly Induces and Co-Localizes with <t>LC3C,</t> an Isomer of LC3, and this Specific Event is Highly Dependent on HSp27 for Successful Autophagic Survival. Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h. P. g was added at MOI 100 to GECs, which were incubated for 6 or 24 h. ( A ) GECs were targeted for P. g (rabbit anti- P. g ; goat anti-rabbit Ultra Small Gold Antibody) and labeled P. g was found to be readily ensconced within double-membraned autophagosomes in GECs. Following HSp27 depletion, P. g appeared to readily start to degrade. Representative transmission electron microscopy images of P. g -infected GECs were also taken at 80 kV and 100000x magnification. Scale bar is 800 nm. ( B ) 6 h and 24h P. g-infected GECs were also stained for P. g (rabbit anti-P . g ; Alexa 488; green) and LC3C (mouse anti-LC3C; Alexa 568; red) to examine whether LC3C characterizes P. g -specific autophagosomes. These cells were then imaged via confocal microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 63x. The range of z-stacks was kept consistent and representative images were selected from the mid-ranged sections. ( Bi ) The Imaris software was utilized to obtain a xoomed 63x Orthogonal Image of 24 h P. g infection and found heightened co-localization between P. g and LC3C. LC3C was found to readily colocalize with P. g, having an average Pearson correlation coefficient of 0.96 via the Imaris post-processing software. ( C ) Lysates of infected and HSp27-depleted GECs were also analyzed via western blotting. Non-target controls were performed and not shown. (Ci) Quantitative ImageJ analysis was performed for the western blot results. Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. **p<.005.
Non Incubated Lc3c Blots, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/HSP+27+Antibody/bio_rxiv__2024__07__01__601539-269-7-14
Average 94 stars, based on 1 article reviews
non incubated lc3c blots - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
CLS Cell Lines Service GmbH human non small cell lung carcinoma a549 cells
Effect of JNK inhibition on <t>A549</t> cell viability as a function of cisplatin concentration. (a, b) 7.5 μg/mL concentration of cisplatin becomes lethal in combination with JNK inhibitor SP600125. However, at higher cisplatin concentrations, the inhibitor either protects against cisplatin-induced cell death (a) or does not have any effect (b). (c) Similar effects are observed in the colon cancer cell line DLD-1. (d–g) SP600125 potentiates the appearance of cells with apoptotic morphology in 7.5 μg/mL cisplatin-treated A549 cells (d, e), in contrast to 30 μg/mL cisplatin-treated A549 cells (f, g). Relative cell viability is cell viability after 72 h treatment normalized by initial viability (measured by the MTT method). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. Fluorescent pictures were obtained with a mixture of AO/EB dyes as described in the section. SP—JNK inhibitor SP600125 (20 μM).
Human Non Small Cell Lung Carcinoma A549 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/A549+Cells/pmc11223245-34-0-9
Average 95 stars, based on 1 article reviews
human non small cell lung carcinoma a549 cells - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology non immune goat igg
FIGURE 2. High glucose promoted PKA-dependent phosphorylation of Hsp90. A, Hsp90 was immunoprecipitated (IP) with an <t>anti-Hsp90</t> anti- body from total lysates (using 1 107 cells/sample) as described under “Experimental Procedures.” Immunoprecipitates were prepared in parallel with <t>non-immune</t> <t>IgG.</t> The resulting samples were subjected to a phos- phospecific PKA substrate Western blot (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). The ratio of the signal from the bottom and top panels is presented. The results show that there was 2.3-fold more phosphorylated Hsp90 in samples prepared from the HG- treated cells as compared with those cultured in normal glucose. In three independent experiments, the fold difference was 2.2 0.2. B, same as A except the HG-treated cells were exposed to the PKA inhibitor PKI (0.5 mol/ liter) for 12 h prior to lysis. The PKI treatment reduced the amount of Hsp90 recognizedbythephospho-PKAsubstrateantibodyby2.6-fold.Inthreeinde- pendent experiments, the average fold difference was 2.7 0.2.
Non Immune Goat Igg, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/mouse+anti-goat+IgG-B/pm17202141-53-37-40
Average 96 stars, based on 1 article reviews
non immune goat igg - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
ATCC human non invasive transitional cell papilloma rt4 cells
Figure 1. Dose- and time-dependent inhibition of bladder cancer cell migration by hAM preparations. (A–E′) Representative images of wound healing of T24 cells. (F–J′) Representative images of wound healing of <t>RT4</t> cells. (K–O′) Representative images of wound healing of NPU cells. (P-R) Percentage of wound healing of T24, RT4 and NPU cells, respectively. Data are presented as mean ± standard error of the mean (SEM) of at least three independent experiments. *P < 0.05 vs. control group. Scale bars 50 µm.
Human Non Invasive Transitional Cell Papilloma Rt4 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/RT4/pm37932474-327-12-23
Average 96 stars, based on 1 article reviews
human non invasive transitional cell papilloma rt4 cells - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

99
ATCC non small cell lung cancer cell line a549
Up, lung cancer cell lines of (A) <t>A549,</t> (B) HCC827, and (C) H1975 were administered with juglanin at different concentrations, ranging from 0 μM to 80 μM for 24 h. Then the cell viability was measured via MTT analysis. And the lung normal cell (D) MRC-5 was also treated with various concentrations of juglanin as indicated for 24 h. Then, MTT assays were conducted to calculate cell viability. Down, the lung cancer cell lines of (A) A549, (B) HCC827, and (C) H1975, and the lung normal cell of MRC-5 were treated with the presented concentrations of juglanin for 48 h, followed by MTT assays. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group without any treatment. (E) A549 and H1975 cells were cultured with 40 μM juglanin for 24 h. Then, flow cytometry assay was conducted to assess DNA contents in the sub-G1 phase. Con: the control group without any treatments. The representative images were exhibited. The quantification of the apoptotic (F) A549 and (G) H1975 cells in sub-G1 phase was calculated through statistic analysis. A549 and H1975 cells were treated with juglanin (10, 20 and 40 μM) for 24 h. The DNA fragmentation assay was conducted to determine DNA fragmentation in (H) A549 and (I) H1975 cells. (J) The representative images of apoptotic morphology of cancer cells treated with or without 40 μM juglanin for 24 h were shown. And the number of apoptotic cells per field was quantified. (K) Transmission electron microscopy was used to observe the chromatin condensation and the apoptotic cells after 40 μM juglanin treatment for 24 h. (L) The representative image of lung cancer cells experiencing apoptosis was displayed. The quantification of (M) A549 and (N) H1975 cells in apoptosis was assessed. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.
Non Small Cell Lung Cancer Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/A549/pmc05706842-292-2-15
Average 99 stars, based on 1 article reviews
non small cell lung cancer cell line a549 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human non small cell lung cancer a549 cells
Fig. 5. Kinetic of cellular uptake of CRISPR-Cas9 system encapsulated in ADGN peptides in cells. (A) Flow cytometry analysis of Cy5-lalelled ADGN peptides encapsulating Cas9 mRNA and Cy3-labelled Luc sgRNA interactions with <t>A549</t> and 3 T3-L1 cells after different times of incubation at a peptide to RNA molar ratio of 20. (B) Quantification of the pourcentage of positive cells analyzed by flow cytometry. Data are means ± SD of three independent experiments with n = 10,000 events/experiment. (C) Internalization of ADGN peptides encapsulating Cas9 mRNA and Luc sgRNA was evaluated on live A549 cells at peptides to RNA molar ratio of 20. Cells were transfected with ADGN peptides labelled with cyanin5 (red color) complexed with Cas9 mRNA and cyanin3-labelled Luc RNA (green color). Cell Mask was used to stain the cells. The cellular uptake was monitored by confocal fluorescence microscopy 30 min and 60 min post-transfection (scale bar: 5 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Human Non Small Cell Lung Cancer A549 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/A549/pm39521064-79-0-7
Average 99 stars, based on 1 article reviews
human non small cell lung cancer a549 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Norgen Biotek plasma serum rna purification mini kit
Fig. 5. Kinetic of cellular uptake of CRISPR-Cas9 system encapsulated in ADGN peptides in cells. (A) Flow cytometry analysis of Cy5-lalelled ADGN peptides encapsulating Cas9 mRNA and Cy3-labelled Luc sgRNA interactions with <t>A549</t> and 3 T3-L1 cells after different times of incubation at a peptide to RNA molar ratio of 20. (B) Quantification of the pourcentage of positive cells analyzed by flow cytometry. Data are means ± SD of three independent experiments with n = 10,000 events/experiment. (C) Internalization of ADGN peptides encapsulating Cas9 mRNA and Luc sgRNA was evaluated on live A549 cells at peptides to RNA molar ratio of 20. Cells were transfected with ADGN peptides labelled with cyanin5 (red color) complexed with Cas9 mRNA and cyanin3-labelled Luc RNA (green color). Cell Mask was used to stain the cells. The cellular uptake was monitored by confocal fluorescence microscopy 30 min and 60 min post-transfection (scale bar: 5 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Plasma Serum Rna Purification Mini Kit, supplied by Norgen Biotek, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/Plasma%2FSerum+RNA+Purification+Kit/10__2147_slash_ijn__s447645-43-25-31
Average 96 stars, based on 1 article reviews
plasma serum rna purification mini kit - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
Norgen Biotek rna isolation kits
Fig. 5. Kinetic of cellular uptake of CRISPR-Cas9 system encapsulated in ADGN peptides in cells. (A) Flow cytometry analysis of Cy5-lalelled ADGN peptides encapsulating Cas9 mRNA and Cy3-labelled Luc sgRNA interactions with <t>A549</t> and 3 T3-L1 cells after different times of incubation at a peptide to RNA molar ratio of 20. (B) Quantification of the pourcentage of positive cells analyzed by flow cytometry. Data are means ± SD of three independent experiments with n = 10,000 events/experiment. (C) Internalization of ADGN peptides encapsulating Cas9 mRNA and Luc sgRNA was evaluated on live A549 cells at peptides to RNA molar ratio of 20. Cells were transfected with ADGN peptides labelled with cyanin5 (red color) complexed with Cas9 mRNA and cyanin3-labelled Luc RNA (green color). Cell Mask was used to stain the cells. The cellular uptake was monitored by confocal fluorescence microscopy 30 min and 60 min post-transfection (scale bar: 5 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Rna Isolation Kits, supplied by Norgen Biotek, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non+redundant+human+proteome+database/Plasma%2FSerum+Exosome+Purification+and+RNA+Isolation+Mini+Kit/bio_rxiv__2025__11__07__686794-219-18-21
Average 94 stars, based on 1 article reviews
rna isolation kits - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


p38 MAPK subtype expression in human CF. (A) Relative mRNA levels for p38 subtypes in CF from 8 different patients quantified using real-time RT-PCR. Data are expressed as percentage of GAPDH mRNA levels (2 −ΔCT × 100) and depicted as a box and whisker plot (box defines 25th–75th interquartile range, whiskers depict full range, and horizontal line is median). (B) Whole cell homogenates of CF (5 patients) or human saphenous vein endothelial cells (2 patients) were immunoblotted for expression of p38 subtypes. Blot reprobed with β-actin antibody to confirm equal loading.

Journal: Biochemical and Biophysical Research Communications

Article Title: p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts

doi: 10.1016/j.bbrc.2012.11.071

Figure Lengend Snippet: p38 MAPK subtype expression in human CF. (A) Relative mRNA levels for p38 subtypes in CF from 8 different patients quantified using real-time RT-PCR. Data are expressed as percentage of GAPDH mRNA levels (2 −ΔCT × 100) and depicted as a box and whisker plot (box defines 25th–75th interquartile range, whiskers depict full range, and horizontal line is median). (B) Whole cell homogenates of CF (5 patients) or human saphenous vein endothelial cells (2 patients) were immunoblotted for expression of p38 subtypes. Blot reprobed with β-actin antibody to confirm equal loading.

Article Snippet: Data are presented as percentage of GAPDH endogenous control mRNA expression (Hs99999905_m1 primers) using the formula 2 −ΔCT × 100.

Techniques: Expressing, Quantitative RT-PCR, Whisker Assay

Effect of p38α gene silencing on p38 MAPK pathway signaling. Cells were mock-transfected or transfected with p38α siRNA before incubation for 4 days. (A) mRNA expression of p38 subtypes measured by RT-PCR. Data expressed as percentage GAPDH mRNA levels. ∗∗∗ P < 0.001, NS = not significant ( n = 5). (B) Protein expression of p38 subtypes measured in parallel cultures by immunoblotting. β-Actin blot confirmed equal protein loading. (C) Mock- or p38α siRNA-transfected CF stimulated with 10 ng/ml TNFα or IL-1α for 20 min. P38 MAPK, MAPKAPK2 and HSP27 phosphorylation and expression determined by immunoblotting. Blots reprobed with β-actin antibody to show equal loading.

Journal: Biochemical and Biophysical Research Communications

Article Title: p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts

doi: 10.1016/j.bbrc.2012.11.071

Figure Lengend Snippet: Effect of p38α gene silencing on p38 MAPK pathway signaling. Cells were mock-transfected or transfected with p38α siRNA before incubation for 4 days. (A) mRNA expression of p38 subtypes measured by RT-PCR. Data expressed as percentage GAPDH mRNA levels. ∗∗∗ P < 0.001, NS = not significant ( n = 5). (B) Protein expression of p38 subtypes measured in parallel cultures by immunoblotting. β-Actin blot confirmed equal protein loading. (C) Mock- or p38α siRNA-transfected CF stimulated with 10 ng/ml TNFα or IL-1α for 20 min. P38 MAPK, MAPKAPK2 and HSP27 phosphorylation and expression determined by immunoblotting. Blots reprobed with β-actin antibody to show equal loading.

Article Snippet: Data are presented as percentage of GAPDH endogenous control mRNA expression (Hs99999905_m1 primers) using the formula 2 −ΔCT × 100.

Techniques: Transfection, Incubation, Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot, Phospho-proteomics

Effect of p38α gene silencing on IL-6 and MMP-3 expression. CF were mock-transfected (open bars) or transfected with p38α siRNA (filled bars), cultured for 4 days to promote p38α protein silencing, then stimulated with 10 ng/ml IL-1α for 6–24 h. (A) Real-time RT-PCR data for mRNA levels of IL-6, MMP-3 and p38α, expressed as percentage GAPDH mRNA levels. ∗∗∗ P < 0.001, ∗ P < 0.05 for effect of gene silencing (6 h, n = 6). (B) ELISA analysis of IL-6 (6 h, n = 5) and MMP-3 (24 h, n = 4) protein levels in conditioned media from IL-1α treated cells. ∗∗ P < 0.01 for effect of gene silencing.

Journal: Biochemical and Biophysical Research Communications

Article Title: p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts

doi: 10.1016/j.bbrc.2012.11.071

Figure Lengend Snippet: Effect of p38α gene silencing on IL-6 and MMP-3 expression. CF were mock-transfected (open bars) or transfected with p38α siRNA (filled bars), cultured for 4 days to promote p38α protein silencing, then stimulated with 10 ng/ml IL-1α for 6–24 h. (A) Real-time RT-PCR data for mRNA levels of IL-6, MMP-3 and p38α, expressed as percentage GAPDH mRNA levels. ∗∗∗ P < 0.001, ∗ P < 0.05 for effect of gene silencing (6 h, n = 6). (B) ELISA analysis of IL-6 (6 h, n = 5) and MMP-3 (24 h, n = 4) protein levels in conditioned media from IL-1α treated cells. ∗∗ P < 0.01 for effect of gene silencing.

Article Snippet: Data are presented as percentage of GAPDH endogenous control mRNA expression (Hs99999905_m1 primers) using the formula 2 −ΔCT × 100.

Techniques: Expressing, Transfection, Cell Culture, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

Intracellular P. gingivalis ( P. g ) Significantly Induces and Co-Localizes with LC3C, an Isomer of LC3, and this Specific Event is Highly Dependent on HSp27 for Successful Autophagic Survival. Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h. P. g was added at MOI 100 to GECs, which were incubated for 6 or 24 h. ( A ) GECs were targeted for P. g (rabbit anti- P. g ; goat anti-rabbit Ultra Small Gold Antibody) and labeled P. g was found to be readily ensconced within double-membraned autophagosomes in GECs. Following HSp27 depletion, P. g appeared to readily start to degrade. Representative transmission electron microscopy images of P. g -infected GECs were also taken at 80 kV and 100000x magnification. Scale bar is 800 nm. ( B ) 6 h and 24h P. g-infected GECs were also stained for P. g (rabbit anti-P . g ; Alexa 488; green) and LC3C (mouse anti-LC3C; Alexa 568; red) to examine whether LC3C characterizes P. g -specific autophagosomes. These cells were then imaged via confocal microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 63x. The range of z-stacks was kept consistent and representative images were selected from the mid-ranged sections. ( Bi ) The Imaris software was utilized to obtain a xoomed 63x Orthogonal Image of 24 h P. g infection and found heightened co-localization between P. g and LC3C. LC3C was found to readily colocalize with P. g, having an average Pearson correlation coefficient of 0.96 via the Imaris post-processing software. ( C ) Lysates of infected and HSp27-depleted GECs were also analyzed via western blotting. Non-target controls were performed and not shown. (Ci) Quantitative ImageJ analysis was performed for the western blot results. Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. **p<.005.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: Intracellular P. gingivalis ( P. g ) Significantly Induces and Co-Localizes with LC3C, an Isomer of LC3, and this Specific Event is Highly Dependent on HSp27 for Successful Autophagic Survival. Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h. P. g was added at MOI 100 to GECs, which were incubated for 6 or 24 h. ( A ) GECs were targeted for P. g (rabbit anti- P. g ; goat anti-rabbit Ultra Small Gold Antibody) and labeled P. g was found to be readily ensconced within double-membraned autophagosomes in GECs. Following HSp27 depletion, P. g appeared to readily start to degrade. Representative transmission electron microscopy images of P. g -infected GECs were also taken at 80 kV and 100000x magnification. Scale bar is 800 nm. ( B ) 6 h and 24h P. g-infected GECs were also stained for P. g (rabbit anti-P . g ; Alexa 488; green) and LC3C (mouse anti-LC3C; Alexa 568; red) to examine whether LC3C characterizes P. g -specific autophagosomes. These cells were then imaged via confocal microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 63x. The range of z-stacks was kept consistent and representative images were selected from the mid-ranged sections. ( Bi ) The Imaris software was utilized to obtain a xoomed 63x Orthogonal Image of 24 h P. g infection and found heightened co-localization between P. g and LC3C. LC3C was found to readily colocalize with P. g, having an average Pearson correlation coefficient of 0.96 via the Imaris post-processing software. ( C ) Lysates of infected and HSp27-depleted GECs were also analyzed via western blotting. Non-target controls were performed and not shown. (Ci) Quantitative ImageJ analysis was performed for the western blot results. Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. **p<.005.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Incubation, Labeling, Transmission Assay, Electron Microscopy, Infection, Staining, Confocal Microscopy, Software, Western Blot, Two Tailed Test

The Autophagic Lifestyle of P. gingivalis (P. g) is Highly Characterized by Only the LC3C Isoform of LC3, Which is not Increased During Starvation-Induced Autophagy in GECs. (A ) The LC3 A/B lipidation results of the same assay provided in . (B ) GECs were separately treated with LC3B siRNA (100nM) for 48h. P. g was added at MOI 100 to GECs for 6 h. Intracellular P. g survival after LC3B siRNA depletion was determined using a standard antibiotic protection assay using P. g- specific 16S rRNA primers. ( C ) GECs were subjected to starvation conditions in HBSS for 24 h. GECs were then collected and fixed so that immunofluorescence could be performed. GECs were stained for LC3C (rabbit anti-LC3C;Alexa 568; red). GECs were then imaged via confocal microscopy (Super Resolution Zeiss Airyscan LSM 880) at 63x. Western blotting (Not Shown) was utilized to confirm the lack of induction of LC3C I and LC3C II. Data is represented as Mean±SD; n=3; p<0.05 is considered statistically significant (Student two-tailed T-test).

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: The Autophagic Lifestyle of P. gingivalis (P. g) is Highly Characterized by Only the LC3C Isoform of LC3, Which is not Increased During Starvation-Induced Autophagy in GECs. (A ) The LC3 A/B lipidation results of the same assay provided in . (B ) GECs were separately treated with LC3B siRNA (100nM) for 48h. P. g was added at MOI 100 to GECs for 6 h. Intracellular P. g survival after LC3B siRNA depletion was determined using a standard antibiotic protection assay using P. g- specific 16S rRNA primers. ( C ) GECs were subjected to starvation conditions in HBSS for 24 h. GECs were then collected and fixed so that immunofluorescence could be performed. GECs were stained for LC3C (rabbit anti-LC3C;Alexa 568; red). GECs were then imaged via confocal microscopy (Super Resolution Zeiss Airyscan LSM 880) at 63x. Western blotting (Not Shown) was utilized to confirm the lack of induction of LC3C I and LC3C II. Data is represented as Mean±SD; n=3; p<0.05 is considered statistically significant (Student two-tailed T-test).

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Immunofluorescence, Staining, Confocal Microscopy, Western Blot, Two Tailed Test

HSp27 Presence Permits the Prolonged Existence of LC3C-characterized, P. gingivalis Specific Autophagosomes by Hampering Canonical Autolysosomal Fusion in Primary GECs. ( A ) Human primary GECs were transfected with mCherry-eGFP-LC3C for 48 h. Select GECs were also treated with 1 uM of the autophagolysosomal fusion inhibitor Bafilomycin A1, 1 uM Pepstatin A, or 5 mM 3-MA. Others were treated with Hsp27 siRNA (100nM) for 24 h. P. g was added at MOI 100 to GECs, which were incubated for 24 h. ( A ) GECs were then stained for P. g (mouse anti- P.g; Alexa 405; blue) and were mounted. GECs were then imaged via confocal microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 63x. ( Ai ) Imaris was used to obtain a zoomed 63x orthogonal image of 24 h P. g infection and measure the high co-localization levels between P. g and the LC3C Reporter System. P. g localized readily to the LC3C construct, with a Pearson correlation coefficient of 0.82. (B) Separately, GECs were additionally stained for P. g (rabbit anti-P . gingivalis ; Alexa 488; green) and LAMP-1 (mouse anti-LAMP-1; Alexa 568; red) and were imaged. The range of all z-stacks was kept consistent and representative images were selected from the mid-ranged sections. Scale bar is 40 µm for 63x Magnification. ( Bi ) Imaris was used to obtain a zoomed 63x orthogonal image of 24 h P. g infection and measure the co-localization levels between P. g and LAMP-1 in infected and treated GECs. While P. g infected GECs did not exhibit high co-localization with LAMP-1 (Pearson correlation coefficient of .25), their HSp27-depleted counterparts did, with an average Pearson correlation coefficient of 0.83. The Scale bar is 20 µm for 63x Magnification. ( C ) Finally, GECs treated with autophagic inhibitors were targeted for P. g (rabbit anti- P. g ; goat anti-rabbit Ultra Small Gold Antibody) and labeled P. g was found to be readily ensconced within double-membraned autophagosomes in GECs. Representative transmission electron microscopy images of P. g -infected GECs were taken at 80 kV and 30000x or 100000x magnification. Following HSp27 depletion, P. g appeared to readily start to degrade, however treatment with late-stage autophagic inhibitors Bafilomycin A1 or Pepstatin A appeared to rescue P. g from degradation. Representative transmission electron microscopy images of P. g -infected GECs were taken at 80 kV and 30000x or 100000x magnification. Scale bar is 800 nm.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: HSp27 Presence Permits the Prolonged Existence of LC3C-characterized, P. gingivalis Specific Autophagosomes by Hampering Canonical Autolysosomal Fusion in Primary GECs. ( A ) Human primary GECs were transfected with mCherry-eGFP-LC3C for 48 h. Select GECs were also treated with 1 uM of the autophagolysosomal fusion inhibitor Bafilomycin A1, 1 uM Pepstatin A, or 5 mM 3-MA. Others were treated with Hsp27 siRNA (100nM) for 24 h. P. g was added at MOI 100 to GECs, which were incubated for 24 h. ( A ) GECs were then stained for P. g (mouse anti- P.g; Alexa 405; blue) and were mounted. GECs were then imaged via confocal microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 63x. ( Ai ) Imaris was used to obtain a zoomed 63x orthogonal image of 24 h P. g infection and measure the high co-localization levels between P. g and the LC3C Reporter System. P. g localized readily to the LC3C construct, with a Pearson correlation coefficient of 0.82. (B) Separately, GECs were additionally stained for P. g (rabbit anti-P . gingivalis ; Alexa 488; green) and LAMP-1 (mouse anti-LAMP-1; Alexa 568; red) and were imaged. The range of all z-stacks was kept consistent and representative images were selected from the mid-ranged sections. Scale bar is 40 µm for 63x Magnification. ( Bi ) Imaris was used to obtain a zoomed 63x orthogonal image of 24 h P. g infection and measure the co-localization levels between P. g and LAMP-1 in infected and treated GECs. While P. g infected GECs did not exhibit high co-localization with LAMP-1 (Pearson correlation coefficient of .25), their HSp27-depleted counterparts did, with an average Pearson correlation coefficient of 0.83. The Scale bar is 20 µm for 63x Magnification. ( C ) Finally, GECs treated with autophagic inhibitors were targeted for P. g (rabbit anti- P. g ; goat anti-rabbit Ultra Small Gold Antibody) and labeled P. g was found to be readily ensconced within double-membraned autophagosomes in GECs. Representative transmission electron microscopy images of P. g -infected GECs were taken at 80 kV and 30000x or 100000x magnification. Following HSp27 depletion, P. g appeared to readily start to degrade, however treatment with late-stage autophagic inhibitors Bafilomycin A1 or Pepstatin A appeared to rescue P. g from degradation. Representative transmission electron microscopy images of P. g -infected GECs were taken at 80 kV and 30000x or 100000x magnification. Scale bar is 800 nm.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Transfection, Incubation, Staining, Confocal Microscopy, Infection, Construct, Labeling, Transmission Assay, Electron Microscopy

Depletion of LC3C via siRNA Collapses P. gingivalis (P. g) -Induced Non-Canonical Autophagosomal Integrity. Human primary GECs were treated with LC3C siRNA (100nM) for 48h. P. g was added at MOI 100 to GECs for 6, 12, or 24 h. ( A ) Intracellular P. g survival after LC3C siRNA depletion was determined using a standard antibiotic protection assay. In brief, any extracellular bacteria were killed via 1h gentamicin (300 μg/mL) and metronidazole (200 μg/mL) treatment. cDNAs were synthesized for qPCR using P. g -specific 16S rRNA primers to quantify intracellular levels of live P. g . Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005. ( B ) P. g -specific autophagosomes were also selectively isolated. Autophagosomes were stained for P. g (rabbit anti- P. g ; Alexa 488; green) and reduced GSH (ThiolTracker Violet; blue). Confocal images of P. g -specific autophagosomes at 6 h post-infection (63x) were taken utilizing the Super Resolution Zeiss Airyscan LSM 880.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: Depletion of LC3C via siRNA Collapses P. gingivalis (P. g) -Induced Non-Canonical Autophagosomal Integrity. Human primary GECs were treated with LC3C siRNA (100nM) for 48h. P. g was added at MOI 100 to GECs for 6, 12, or 24 h. ( A ) Intracellular P. g survival after LC3C siRNA depletion was determined using a standard antibiotic protection assay. In brief, any extracellular bacteria were killed via 1h gentamicin (300 μg/mL) and metronidazole (200 μg/mL) treatment. cDNAs were synthesized for qPCR using P. g -specific 16S rRNA primers to quantify intracellular levels of live P. g . Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005. ( B ) P. g -specific autophagosomes were also selectively isolated. Autophagosomes were stained for P. g (rabbit anti- P. g ; Alexa 488; green) and reduced GSH (ThiolTracker Violet; blue). Confocal images of P. g -specific autophagosomes at 6 h post-infection (63x) were taken utilizing the Super Resolution Zeiss Airyscan LSM 880.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Bacteria, Synthesized, Two Tailed Test, Isolation, Staining, Infection

P. gingivalis (P. g) Causes the Nucleation of Hsp27-Mediated LC3C Accumulation and Lipidation; this Specific Assembly is Highly Dependent on Host Cells’ Redox Potential Determined by eATP Treatments. Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h. P. g was added at MOI 100 to GECs, which were incubated 6 and 24 h. Non-Depleted and HSp27-depleted GECs also were treated with the physiologically-relevant oxidative stress inducer eATP (3mM) treatment for 30 min prior to infection, and were analyzed by western blot.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: P. gingivalis (P. g) Causes the Nucleation of Hsp27-Mediated LC3C Accumulation and Lipidation; this Specific Assembly is Highly Dependent on Host Cells’ Redox Potential Determined by eATP Treatments. Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h. P. g was added at MOI 100 to GECs, which were incubated 6 and 24 h. Non-Depleted and HSp27-depleted GECs also were treated with the physiologically-relevant oxidative stress inducer eATP (3mM) treatment for 30 min prior to infection, and were analyzed by western blot.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Incubation, Infection, Western Blot

P. gingivalis ( P. g ) Induces and Prolongs the Autophagosomal LC3C/Beclin 1/ATG14 Nucleation Complex in a Manner Dependent upon HSp27 and the Reduced Redox State of Infected GECs as Determined by Isolated P. g- Specific Autophagosomes. GECs were treated with HSP27siRNA (100nM) for 48 h. Select GECs were also treated with N-acetyl Cysteine (NAC)(50 uM) for 1 h and/or eATP (3mM) for 30 min. P. g was added at MOI 100 to GECs, which were incubated 6 and 12 h. Autophagosomes were then isolated and prepared for analysis. ( A ) The glutathione (GSH) levels of primary GECs were also measured using chemiluminescence detection. ( B) Isolated autophagosomes were analyzed via western blot. ( Bi ), ( Bii ), ( Biii ) Quantitative ImageJ analysis was performed of each of the western blot results. Data is represented as Mean±SD, where n=3 for results. p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: P. gingivalis ( P. g ) Induces and Prolongs the Autophagosomal LC3C/Beclin 1/ATG14 Nucleation Complex in a Manner Dependent upon HSp27 and the Reduced Redox State of Infected GECs as Determined by Isolated P. g- Specific Autophagosomes. GECs were treated with HSP27siRNA (100nM) for 48 h. Select GECs were also treated with N-acetyl Cysteine (NAC)(50 uM) for 1 h and/or eATP (3mM) for 30 min. P. g was added at MOI 100 to GECs, which were incubated 6 and 12 h. Autophagosomes were then isolated and prepared for analysis. ( A ) The glutathione (GSH) levels of primary GECs were also measured using chemiluminescence detection. ( B) Isolated autophagosomes were analyzed via western blot. ( Bi ), ( Bii ), ( Biii ) Quantitative ImageJ analysis was performed of each of the western blot results. Data is represented as Mean±SD, where n=3 for results. p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Infection, Isolation, Incubation, Western Blot, Two Tailed Test

HSp27 and LC3C Recruit Beclin 1 and ATG14 to Form a Temporal Pro-bacterial Autophagic Complex, which Can Be Disrupted by Increased Oxidative Stress. Human Primary GECs were treated with HSp27siRNA (100nM) for 48 h. Select GECs were also treated with N-acetyl Cysteine (NAC) (50 uM) for 1 h and/or eATP (3mM) for 30 min. P. gingivalis (P. g) was added at MOI 100 to GECs, which were incubated 6 and 12 h. GECs were then lysed and the extracts were incubated in rabbit anti-LC3C antibody over-night. Samples underwent co-immunoprecipitation. ( A ) The eluted protein complexes were then analyzed by western blot. ( Ai ), ( Aii ), and ( Aiii ) Quantitative ImageJ analysis of western blot results was performed for each of the proteins in question. ( B ) GECs also underwent staining for HSp27 (goat anti-HSp27; Alexa 405; blue), LC3C (rabbit anti-LC3C; Alexa 488; green), and Beclin 1 (sheep anti-Beclin 1; Alexa 568; red), and ATG14 (mouse anti-ATG14; Alexa 647; magenta) to examine the formation of the pro-bacterial autophagic initiation complex. GECs were then imaged via Leica DM6 CS Stellaris 5 Confocal/Multiphoton System at 63x. The Imaris software was used to obtain zoomed orthogonal views of ( Bi ) An infected GECs and ( Bii ) a theoretical autophagosome with HSp27, LC3C, ATG14, and Beclin 1 highly co-localized about it. The scale bar is 20 µm for all Magnification. All of the markers were found to have a Pearson correlation coefficient greater than .9 with each other via Imaris, denoting their close theorized interactions. Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: HSp27 and LC3C Recruit Beclin 1 and ATG14 to Form a Temporal Pro-bacterial Autophagic Complex, which Can Be Disrupted by Increased Oxidative Stress. Human Primary GECs were treated with HSp27siRNA (100nM) for 48 h. Select GECs were also treated with N-acetyl Cysteine (NAC) (50 uM) for 1 h and/or eATP (3mM) for 30 min. P. gingivalis (P. g) was added at MOI 100 to GECs, which were incubated 6 and 12 h. GECs were then lysed and the extracts were incubated in rabbit anti-LC3C antibody over-night. Samples underwent co-immunoprecipitation. ( A ) The eluted protein complexes were then analyzed by western blot. ( Ai ), ( Aii ), and ( Aiii ) Quantitative ImageJ analysis of western blot results was performed for each of the proteins in question. ( B ) GECs also underwent staining for HSp27 (goat anti-HSp27; Alexa 405; blue), LC3C (rabbit anti-LC3C; Alexa 488; green), and Beclin 1 (sheep anti-Beclin 1; Alexa 568; red), and ATG14 (mouse anti-ATG14; Alexa 647; magenta) to examine the formation of the pro-bacterial autophagic initiation complex. GECs were then imaged via Leica DM6 CS Stellaris 5 Confocal/Multiphoton System at 63x. The Imaris software was used to obtain zoomed orthogonal views of ( Bi ) An infected GECs and ( Bii ) a theoretical autophagosome with HSp27, LC3C, ATG14, and Beclin 1 highly co-localized about it. The scale bar is 20 µm for all Magnification. All of the markers were found to have a Pearson correlation coefficient greater than .9 with each other via Imaris, denoting their close theorized interactions. Data is represented as Mean±SD, where n=3 and p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Incubation, Immunoprecipitation, Western Blot, Staining, Software, Infection, Two Tailed Test

HSp27 and LC3C Selectively and Specifically Partner with One Another to Promote P. gingivalis ( P. g )-Induced Autophagy. P. g was added at MOI 100 to Human Primary GECs, which were incubated 6 and 24 h. ( A ) GECs were stained for LC3C (rabbit anti-LC3C; Alexa 488; green) and HSp27 (mouse anti-HSp37; Alexa 568; red) following infection. HSp27 was found to readily and temporally colocalize with LC3C, having a Pearsons correlation coefficient of .85 at 24 h post infection via the Imaris post-processing software. ( B ) To assess if full length HSp27 is truly capable of binding to full-length LC3C, a far western approach was implemented by probing 5 µg of recombinant LC3C with 10 µg of recombinant HSp27 for one hour. Antibody specificity was accounted for via probing the LC3C blot with monoclonal mouse anti-HSp27 antibody (Not shown), which showed no cross-reactivity.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: HSp27 and LC3C Selectively and Specifically Partner with One Another to Promote P. gingivalis ( P. g )-Induced Autophagy. P. g was added at MOI 100 to Human Primary GECs, which were incubated 6 and 24 h. ( A ) GECs were stained for LC3C (rabbit anti-LC3C; Alexa 488; green) and HSp27 (mouse anti-HSp37; Alexa 568; red) following infection. HSp27 was found to readily and temporally colocalize with LC3C, having a Pearsons correlation coefficient of .85 at 24 h post infection via the Imaris post-processing software. ( B ) To assess if full length HSp27 is truly capable of binding to full-length LC3C, a far western approach was implemented by probing 5 µg of recombinant LC3C with 10 µg of recombinant HSp27 for one hour. Antibody specificity was accounted for via probing the LC3C blot with monoclonal mouse anti-HSp27 antibody (Not shown), which showed no cross-reactivity.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Incubation, Staining, Infection, Software, Binding Assay, Western Blot, Recombinant

HSp27 does not Interact with either LC3A or LC3B isoforms in the way that it interacts with LC3C. A Far Western approach was implemented. rLC3A or rLC3B were loaded and incubated with 10 ug of rHSp27. Interactions for ( Bi ) LC3A and ( Bii ) LC3B were then detected by probing the rLC3A or rLC3B blot with mouse Anti-Hsp27 antibody.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: HSp27 does not Interact with either LC3A or LC3B isoforms in the way that it interacts with LC3C. A Far Western approach was implemented. rLC3A or rLC3B were loaded and incubated with 10 ug of rHSp27. Interactions for ( Bi ) LC3A and ( Bii ) LC3B were then detected by probing the rLC3A or rLC3B blot with mouse Anti-Hsp27 antibody.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Western Blot, Incubation

Phosphorylated HSp27 (P-HSp27) Preferentially Binds to the C-terminal Tail of LC3C, Inhibiting the Canonical Cleavage of LC3C and Halting the Canonical Maturation of LC3C-Specific Autophagosomes. The structural models of monomeric full-length wild-type ( A ) HSp27 (Uniprot: P04792) and ( B ) LC3C (Uniprot: Q9BXW4) were acquired from the AlphaFold database. Optimized complex configurations between ( C ) LC3C and unmodified HSp27 and ( D ) LC3C and P-HSp27 were then obtained, and the modifications in the theorized interaction sites in their N-terminal regions were highlighted. ( E ) Surface electrostatic potentials of the complexes were additionally mapped, contrasting the varied potentials between the two complexes. ( F ) Finally, the buried surface areas and interaction areas between HSp27 or P-HSp27 and LC3C proteins were also assessed and contact maps were generated.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: Phosphorylated HSp27 (P-HSp27) Preferentially Binds to the C-terminal Tail of LC3C, Inhibiting the Canonical Cleavage of LC3C and Halting the Canonical Maturation of LC3C-Specific Autophagosomes. The structural models of monomeric full-length wild-type ( A ) HSp27 (Uniprot: P04792) and ( B ) LC3C (Uniprot: Q9BXW4) were acquired from the AlphaFold database. Optimized complex configurations between ( C ) LC3C and unmodified HSp27 and ( D ) LC3C and P-HSp27 were then obtained, and the modifications in the theorized interaction sites in their N-terminal regions were highlighted. ( E ) Surface electrostatic potentials of the complexes were additionally mapped, contrasting the varied potentials between the two complexes. ( F ) Finally, the buried surface areas and interaction areas between HSp27 or P-HSp27 and LC3C proteins were also assessed and contact maps were generated.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Generated

P. gingivalis (P. g) Secretes its Ndk Effector Molecule to Activate HSp27 and Induce Temporal HSp27-LC3C Partnering to Inhibit Canonical LC3C Cleavage by ATG4B and Halt Autolyosomal Fusion in GECs. A) Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h or were transfected with 1 µg of the constitutively activated pFLAG-CMV2-HSP27-S78D/S82D construct for 48h. Select GECs were then jointly treated with the late stage autophagy inhibitors 1 µM Pepstatin A, or 1 µM lactostatin for 24h. Wild-type P. g or ΔNDK P. g was then added at MOI 100 to GECs, which were incubated for 24 h. ( A ) GECs also underwent staining for HSp27 (goat anti-HSp27; Alexa 405; blue), LC3C (rabbit anti-LC3C; Alexa 488; green), and Beclin 1 (sheep anti-Beclin 1; Alexa 568; red), and ATG14 (mouse anti-ATG14; Alexa 647; magenta) to examine the formation of the pro-bacterial autophagic initiation complex. GECs were then imaged via Leica DM6 CS Stellaris 5 Confocal/Multiphoton System at 63x. ( B ) A diagram was created detailing how LC3C preferentially partners to P-HSp27 over its non-phosphorylated counterpart, causing a confirmational shift to the C-terminal tail of LC3C. This shift results in the inhibition of the final lipidated LC3C tail cleavage by the ATG4B protease, lending to LC3C not disassociating from the autophagosome and halting fusion with the lysosome. ( C ) A diagram was also created to highlight the temporal relationship between HSp27 and LC3C, where LC3C can initially bind to HSp27 but via the actions of Ndk, it preferentially binds to P-HSp27, resulting in a limiting of mature, cleaved LC3C.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: P. gingivalis (P. g) Secretes its Ndk Effector Molecule to Activate HSp27 and Induce Temporal HSp27-LC3C Partnering to Inhibit Canonical LC3C Cleavage by ATG4B and Halt Autolyosomal Fusion in GECs. A) Human primary GECs were treated with HSp27 siRNA (100nM) for 48 h or were transfected with 1 µg of the constitutively activated pFLAG-CMV2-HSP27-S78D/S82D construct for 48h. Select GECs were then jointly treated with the late stage autophagy inhibitors 1 µM Pepstatin A, or 1 µM lactostatin for 24h. Wild-type P. g or ΔNDK P. g was then added at MOI 100 to GECs, which were incubated for 24 h. ( A ) GECs also underwent staining for HSp27 (goat anti-HSp27; Alexa 405; blue), LC3C (rabbit anti-LC3C; Alexa 488; green), and Beclin 1 (sheep anti-Beclin 1; Alexa 568; red), and ATG14 (mouse anti-ATG14; Alexa 647; magenta) to examine the formation of the pro-bacterial autophagic initiation complex. GECs were then imaged via Leica DM6 CS Stellaris 5 Confocal/Multiphoton System at 63x. ( B ) A diagram was created detailing how LC3C preferentially partners to P-HSp27 over its non-phosphorylated counterpart, causing a confirmational shift to the C-terminal tail of LC3C. This shift results in the inhibition of the final lipidated LC3C tail cleavage by the ATG4B protease, lending to LC3C not disassociating from the autophagosome and halting fusion with the lysosome. ( C ) A diagram was also created to highlight the temporal relationship between HSp27 and LC3C, where LC3C can initially bind to HSp27 but via the actions of Ndk, it preferentially binds to P-HSp27, resulting in a limiting of mature, cleaved LC3C.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Transfection, Construct, Incubation, Staining, Inhibition

Cross-Sectional Human in Situ Sample and Expression Analyses Support High Levels and Increased Co-localization of P. gingivalis (P. g) , HSp27, and LC3C in Periodontitis-Afflicted Oral Tissues. Publicly available mRNA expression data (GEO accession: GSE79705) was obtained from previously collected and examined periodontitis-afflicted and healthy gingival tissues. This microarray expression data was then analyzed via GEO2R and the relative levels of ( A ) HSp27 and ( B ) LC3C were obtained and compared. Data is represented as Mean±SD, where n=12 and p<0.05 was considered as statistically significant via One-Way Anova. *p<0.05. Representative confocal images of gingival biopsy specimens from healthy individuals and periodontitis-afflicted patients were also taken and examined. DAPI staining was utilized to visualize cellular DNA. ( C ) P. g (mouse anti-P . gingivalis ; Alexa 488; green) and LC3C (rabbit anti-LC3C; Alexa 594; red) were detected via dual staining. ( D ) HSp27 (mouse anti-HSp27; Alexa 488; green) and LC3C detection (rabbit anti-LC3C; Alexa 594; red) were also detected. Images were then captured using super resolution confocal laser scanning microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 10x and 63x magnification with oil immersion. Zoomed (2x) 3D versions of the 63x magnifications were obtained via the Imaris software. The range of z-stacks was kept consistent. SC: Stratum corneum, SL: Stratum lucidum, SG: Stratum granulosum, SB: Stratum basale, LT: Lamina propria. Scale bars = 200µm for 10x and 20 µm for 63x. Quantification of mean fluorescence intensity provided in Supplement. LC3C and HSp27 both were found to exhibit high levels of co-localization with each other and with P. g, as the Pearson coefficient was calculated to be .93 for LC3C and P. g and .85 for LC3C and HSp27 via the Imaris Software at the most severe state of disease.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: Cross-Sectional Human in Situ Sample and Expression Analyses Support High Levels and Increased Co-localization of P. gingivalis (P. g) , HSp27, and LC3C in Periodontitis-Afflicted Oral Tissues. Publicly available mRNA expression data (GEO accession: GSE79705) was obtained from previously collected and examined periodontitis-afflicted and healthy gingival tissues. This microarray expression data was then analyzed via GEO2R and the relative levels of ( A ) HSp27 and ( B ) LC3C were obtained and compared. Data is represented as Mean±SD, where n=12 and p<0.05 was considered as statistically significant via One-Way Anova. *p<0.05. Representative confocal images of gingival biopsy specimens from healthy individuals and periodontitis-afflicted patients were also taken and examined. DAPI staining was utilized to visualize cellular DNA. ( C ) P. g (mouse anti-P . gingivalis ; Alexa 488; green) and LC3C (rabbit anti-LC3C; Alexa 594; red) were detected via dual staining. ( D ) HSp27 (mouse anti-HSp27; Alexa 488; green) and LC3C detection (rabbit anti-LC3C; Alexa 594; red) were also detected. Images were then captured using super resolution confocal laser scanning microscopy (Leica DM6 CS Stellaris 5 Confocal/Multiphoton System) at 10x and 63x magnification with oil immersion. Zoomed (2x) 3D versions of the 63x magnifications were obtained via the Imaris software. The range of z-stacks was kept consistent. SC: Stratum corneum, SL: Stratum lucidum, SG: Stratum granulosum, SB: Stratum basale, LT: Lamina propria. Scale bars = 200µm for 10x and 20 µm for 63x. Quantification of mean fluorescence intensity provided in Supplement. LC3C and HSp27 both were found to exhibit high levels of co-localization with each other and with P. g, as the Pearson coefficient was calculated to be .93 for LC3C and P. g and .85 for LC3C and HSp27 via the Imaris Software at the most severe state of disease.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: In Situ, Expressing, Microarray, Staining, Confocal Laser Scanning Microscopy, Software, Fluorescence

Quantifications of Cross-Sectional Human Ex-Vivo Samples Support High Levels of P. gingivalis (P. g) , HSp27, and LC3C in Chronically Diseased Oral Tissues (i.e. Periodontitis). Representative confocal images of gingival biopsy specimens from healthy individuals and periodontitis patients were obtained using the Leica DM6 CS Stellaris 5 Confocal/Multiphoton System so that the mean fluorescence intensity of ( A ) HSp27 ( B ) P. g and ( C ) LC3C could be calculated using ImageJ with JACoP Plugin. Data are presented as mean ± SD. Representative images from at least 5 different patients per group were used for quantitative analysis and p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: Quantifications of Cross-Sectional Human Ex-Vivo Samples Support High Levels of P. gingivalis (P. g) , HSp27, and LC3C in Chronically Diseased Oral Tissues (i.e. Periodontitis). Representative confocal images of gingival biopsy specimens from healthy individuals and periodontitis patients were obtained using the Leica DM6 CS Stellaris 5 Confocal/Multiphoton System so that the mean fluorescence intensity of ( A ) HSp27 ( B ) P. g and ( C ) LC3C could be calculated using ImageJ with JACoP Plugin. Data are presented as mean ± SD. Representative images from at least 5 different patients per group were used for quantitative analysis and p<0.05 was considered as statistically significant via Student two-tailed T-test. *p<.05 **p<.005

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Ex Vivo, Fluorescence, Two Tailed Test

HSp27 is a Critical Regulator in Pro-bacterial LC3C-Characterized Autophagy, Facilitating the Intracellular Autophagic Survival of P. gingivalis (P. g) and Influencing the Bacterial Symbiosis of the Oral Mucosa. The proposed diagram of the identified mechanisms of P. gingivalis persistence in GECs. ( A ) HSp27 is largely induced and spatially recruited by P. g invasion of the host cells. After the initial periods of cellular infection, the gradually growing secretion of the bacterial Nucleoside-diphosphate-kinase (Ndk) into the cytoplasmic space causes heightened activation of HSp27 (P-HSp27) via direct phosphorylation. P-HSp27 abrogates extracellular ATP (eATP)-induced antimicrobial Reactive-Oxygen-Species (ROS) production via increasing glutathione (GSH) levels. In parallel, P. g -mediated induction of HSp27 promotes the specific recruitment and lipidation of LC3C, an isomer of the LC3 autophagosomal structural molecule, which is strictly dependent upon the large presence and the strong antioxidant activity of HSp27. LC3C and HSp27 partner in a stepwise manner, 1) their coupling drives the formation of Beclin1/ATG14 induction, 2) where the temporally increased phosphorylation of HSp27 by P. g Ndk both strengthens the P-HSP27 and LC3C partnering and shifts the confirmation of the LC3C tail so that LC3C cannot be successfully further cleaved by ATG4. ( B ) P-HSp27 and LC3C become increasingly assembled to the ATG14-Incorperated Nucleation Complex, where they prolong the complex’s formation and result in the accumulation of the complex on forming autophagic membranes. Thus, the strengthened partnering between P-HSp27 and LC3C is the proposed mechanism for inhibiting the autolysosomal fusion of P. g- specific autophagosomes, which is also controlled by the host cell redox homeostasis ( C ) Autophagic P. g does not undergo lysosomal degradation and is instead able to survive, multiply and subsequently intercellularly spread to neighboring cells to propagate. ( D ) Thus, the non-canonical, pro-bacterial autophagic events create a favorable and protected cellular environment for P. g , thereby establishing long-term intracellular bacterial persistence. The chronic colonization of P. g in the epithelia can lead to host-microbial dysbiosis in oral mucosa and systemic disorders.

Journal: bioRxiv

Article Title: Porphyromonas gingivalis activates Heat-Shock-Protein 27 to drive a LC3C-specific probacterial form of select autophagy that is redox sensitive for intracellular bacterial survival in human gingival mucosa

doi: 10.1101/2024.07.01.601539

Figure Lengend Snippet: HSp27 is a Critical Regulator in Pro-bacterial LC3C-Characterized Autophagy, Facilitating the Intracellular Autophagic Survival of P. gingivalis (P. g) and Influencing the Bacterial Symbiosis of the Oral Mucosa. The proposed diagram of the identified mechanisms of P. gingivalis persistence in GECs. ( A ) HSp27 is largely induced and spatially recruited by P. g invasion of the host cells. After the initial periods of cellular infection, the gradually growing secretion of the bacterial Nucleoside-diphosphate-kinase (Ndk) into the cytoplasmic space causes heightened activation of HSp27 (P-HSp27) via direct phosphorylation. P-HSp27 abrogates extracellular ATP (eATP)-induced antimicrobial Reactive-Oxygen-Species (ROS) production via increasing glutathione (GSH) levels. In parallel, P. g -mediated induction of HSp27 promotes the specific recruitment and lipidation of LC3C, an isomer of the LC3 autophagosomal structural molecule, which is strictly dependent upon the large presence and the strong antioxidant activity of HSp27. LC3C and HSp27 partner in a stepwise manner, 1) their coupling drives the formation of Beclin1/ATG14 induction, 2) where the temporally increased phosphorylation of HSp27 by P. g Ndk both strengthens the P-HSP27 and LC3C partnering and shifts the confirmation of the LC3C tail so that LC3C cannot be successfully further cleaved by ATG4. ( B ) P-HSp27 and LC3C become increasingly assembled to the ATG14-Incorperated Nucleation Complex, where they prolong the complex’s formation and result in the accumulation of the complex on forming autophagic membranes. Thus, the strengthened partnering between P-HSp27 and LC3C is the proposed mechanism for inhibiting the autolysosomal fusion of P. g- specific autophagosomes, which is also controlled by the host cell redox homeostasis ( C ) Autophagic P. g does not undergo lysosomal degradation and is instead able to survive, multiply and subsequently intercellularly spread to neighboring cells to propagate. ( D ) Thus, the non-canonical, pro-bacterial autophagic events create a favorable and protected cellular environment for P. g , thereby establishing long-term intracellular bacterial persistence. The chronic colonization of P. g in the epithelia can lead to host-microbial dysbiosis in oral mucosa and systemic disorders.

Article Snippet: Antibody cross-reactivity was accounted for via probing non-incubated LC3C blots with mouse anti-HSp27 antibody (Santa Cruz Biotechnology, sc-13132; 1:1000).

Techniques: Infection, Activation Assay, Phospho-proteomics, Antioxidant Activity Assay

Effect of JNK inhibition on A549 cell viability as a function of cisplatin concentration. (a, b) 7.5 μg/mL concentration of cisplatin becomes lethal in combination with JNK inhibitor SP600125. However, at higher cisplatin concentrations, the inhibitor either protects against cisplatin-induced cell death (a) or does not have any effect (b). (c) Similar effects are observed in the colon cancer cell line DLD-1. (d–g) SP600125 potentiates the appearance of cells with apoptotic morphology in 7.5 μg/mL cisplatin-treated A549 cells (d, e), in contrast to 30 μg/mL cisplatin-treated A549 cells (f, g). Relative cell viability is cell viability after 72 h treatment normalized by initial viability (measured by the MTT method). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. Fluorescent pictures were obtained with a mixture of AO/EB dyes as described in the section. SP—JNK inhibitor SP600125 (20 μM).

Journal: ACS Omega

Article Title: The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

doi: 10.1021/acsomega.4c01950

Figure Lengend Snippet: Effect of JNK inhibition on A549 cell viability as a function of cisplatin concentration. (a, b) 7.5 μg/mL concentration of cisplatin becomes lethal in combination with JNK inhibitor SP600125. However, at higher cisplatin concentrations, the inhibitor either protects against cisplatin-induced cell death (a) or does not have any effect (b). (c) Similar effects are observed in the colon cancer cell line DLD-1. (d–g) SP600125 potentiates the appearance of cells with apoptotic morphology in 7.5 μg/mL cisplatin-treated A549 cells (d, e), in contrast to 30 μg/mL cisplatin-treated A549 cells (f, g). Relative cell viability is cell viability after 72 h treatment normalized by initial viability (measured by the MTT method). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. Fluorescent pictures were obtained with a mixture of AO/EB dyes as described in the section. SP—JNK inhibitor SP600125 (20 μM).

Article Snippet: Human non-small-cell lung carcinoma A549 cells were purchased from Cell Lines Service GmbH, Eppelheim, Germany.

Techniques: Inhibition, Concentration Assay

JNK inhibitor SP600125 reduces JNK target transcription factor c-Jun phosphorylation in cisplatin-treated A549 cells. Different concentrations of cisplatin were used. (a) Representative Western blots from 20 and 40 h of treatments are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls. (b) Repeated addition (after 24 h) of SP potentiates suppression of c-Jun phosphorylation in response to cisplatin treatment. (c) Repeated addition of SP strengthens the protective effect of JNK inhibition at 15−30 μg/mL concentrations of cisplatin in A549 cells. SP—JNK inhibitor SP600125 (20 μM). p *** < 0.0005, N = 3.

Journal: ACS Omega

Article Title: The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

doi: 10.1021/acsomega.4c01950

Figure Lengend Snippet: JNK inhibitor SP600125 reduces JNK target transcription factor c-Jun phosphorylation in cisplatin-treated A549 cells. Different concentrations of cisplatin were used. (a) Representative Western blots from 20 and 40 h of treatments are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls. (b) Repeated addition (after 24 h) of SP potentiates suppression of c-Jun phosphorylation in response to cisplatin treatment. (c) Repeated addition of SP strengthens the protective effect of JNK inhibition at 15−30 μg/mL concentrations of cisplatin in A549 cells. SP—JNK inhibitor SP600125 (20 μM). p *** < 0.0005, N = 3.

Article Snippet: Human non-small-cell lung carcinoma A549 cells were purchased from Cell Lines Service GmbH, Eppelheim, Germany.

Techniques: Phospho-proteomics, Western Blot, Staining, Inhibition

Cisplatin concentration-dependent effect of different JNK inhibitors on A549 cell viability. Different JNK inhibitors show the same dependence on cisplatin concentration on cell viability. Statistically significant reduction in cell viability is observed at 7.5 μg/mL cisplatin in combination with 10 μM AS601245 (a), 10 μM bentamapimod (b), 2 μM JNK inhibitor IX (c), and 5 μM XG-102 (d). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. (e) Reduction in c-Jun phosphorylation upon the addition of JNK inhibitor XG-102, as determined by Western blot. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls.

Journal: ACS Omega

Article Title: The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

doi: 10.1021/acsomega.4c01950

Figure Lengend Snippet: Cisplatin concentration-dependent effect of different JNK inhibitors on A549 cell viability. Different JNK inhibitors show the same dependence on cisplatin concentration on cell viability. Statistically significant reduction in cell viability is observed at 7.5 μg/mL cisplatin in combination with 10 μM AS601245 (a), 10 μM bentamapimod (b), 2 μM JNK inhibitor IX (c), and 5 μM XG-102 (d). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. (e) Reduction in c-Jun phosphorylation upon the addition of JNK inhibitor XG-102, as determined by Western blot. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls.

Article Snippet: Human non-small-cell lung carcinoma A549 cells were purchased from Cell Lines Service GmbH, Eppelheim, Germany.

Techniques: Concentration Assay, Phospho-proteomics, Western Blot, Staining

Activation of TP53 in A549 cells in response to different concentrations of cisplatin. (a, b) Expression and phosphorylation at serine-6 is induced by cisplatin and is maximal at 15 μg/mL (6 h of cisplatin treatment). (c, d) Prolonged and increasing expression and phosphorylation of TP53 in cells treated with either 7.5 μg/mL or 30 μg/mL of cisplatin. (e) TP53 activator nutlin-3a potentiates cisplatin-induced decrease in cell viability. (f) Nutlin-3a reduces viability of cisplatin + SP600125-treated cells. C—control without cisplatin; Nut—nutlin-3a (10 μM); SP—SP600125 (20 μM). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented, p ** < 0.005, p *** < 0.0005, N = 4. (g) Nutlin induces expression of TP53. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls.

Journal: ACS Omega

Article Title: The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

doi: 10.1021/acsomega.4c01950

Figure Lengend Snippet: Activation of TP53 in A549 cells in response to different concentrations of cisplatin. (a, b) Expression and phosphorylation at serine-6 is induced by cisplatin and is maximal at 15 μg/mL (6 h of cisplatin treatment). (c, d) Prolonged and increasing expression and phosphorylation of TP53 in cells treated with either 7.5 μg/mL or 30 μg/mL of cisplatin. (e) TP53 activator nutlin-3a potentiates cisplatin-induced decrease in cell viability. (f) Nutlin-3a reduces viability of cisplatin + SP600125-treated cells. C—control without cisplatin; Nut—nutlin-3a (10 μM); SP—SP600125 (20 μM). Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented, p ** < 0.005, p *** < 0.0005, N = 4. (g) Nutlin induces expression of TP53. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls.

Article Snippet: Human non-small-cell lung carcinoma A549 cells were purchased from Cell Lines Service GmbH, Eppelheim, Germany.

Techniques: Activation Assay, Expressing, Phospho-proteomics, Control, Western Blot, Staining

Involvement of AKT signaling pathway in cisplatin-induced A549 cell death. (a) AKT protein level does not depend on cisplatin concentration. 6-h-long exposure is presented in the Western blot picture. (b) Phosphorylation/activation of AKT is cisplatin concentration-dependent. 6-h-long exposure is presented in the Western blot picture. (c) AKT protein level does not change during 40 h of cisplatin treatment. (d) Dynamics of AKT activation following cisplatin (7.5 or 30 μg/mL) treatment. (e, f) AKT inhibitor capivasertib enhances cell death at all concentrations of cisplatin used both in the absence (e) and presence (f) of JNK inhibitor SP600125. (g, h) GSK3-β inhibitor SB415286 protects A549 cells from cisplatin both in the absence (g) and presence (h) of JNK inhibition. Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. p*<0.05, p**<0.005, p***<0.0005, N = 4. (i) Capivasertib inhibits AKT activity as shown by the inhibition of AKT molecular target GSK3-β phosphorylation at serine-9. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls. C—control without cisplatin; CAP—capivasertib (10 μM); SP—SP600125 (20 μM), SB—GSK3 inhibitor SB415286 (15 μM).

Journal: ACS Omega

Article Title: The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

doi: 10.1021/acsomega.4c01950

Figure Lengend Snippet: Involvement of AKT signaling pathway in cisplatin-induced A549 cell death. (a) AKT protein level does not depend on cisplatin concentration. 6-h-long exposure is presented in the Western blot picture. (b) Phosphorylation/activation of AKT is cisplatin concentration-dependent. 6-h-long exposure is presented in the Western blot picture. (c) AKT protein level does not change during 40 h of cisplatin treatment. (d) Dynamics of AKT activation following cisplatin (7.5 or 30 μg/mL) treatment. (e, f) AKT inhibitor capivasertib enhances cell death at all concentrations of cisplatin used both in the absence (e) and presence (f) of JNK inhibitor SP600125. (g, h) GSK3-β inhibitor SB415286 protects A549 cells from cisplatin both in the absence (g) and presence (h) of JNK inhibition. Representative test results (all measurements were performed in quadruplicate) from more than five experiments are presented. p*<0.05, p**<0.005, p***<0.0005, N = 4. (i) Capivasertib inhibits AKT activity as shown by the inhibition of AKT molecular target GSK3-β phosphorylation at serine-9. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as loading controls. C—control without cisplatin; CAP—capivasertib (10 μM); SP—SP600125 (20 μM), SB—GSK3 inhibitor SB415286 (15 μM).

Article Snippet: Human non-small-cell lung carcinoma A549 cells were purchased from Cell Lines Service GmbH, Eppelheim, Germany.

Techniques: Concentration Assay, Western Blot, Phospho-proteomics, Activation Assay, Inhibition, Activity Assay, Staining, Control

Opposite changes in TP53 and AKT phosphorylation following SP600125 treatment of A549 cells exposed to different concentrations of cisplatin. (a) Expression of TP53 is increased in response to the combination of SP + 7.5 μg/mL cisplatin, in contrast to the combination of SP + 30 μg/mL cisplatin. (b) Phosphorylation of TP53 (serine-6) is increased in response to the combination of SP + 7.5 μg/mL cisplatin, in contrast to the combination of SP + 30 μg/mL cisplatin. (c) Phosphorylation of AKT (threonine-308) is decreased in response to the combination of SP + 7.5 μg/mL cisplatin, in contrast to the combination of SP + 30 μg/mL cisplatin. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as a loading control. SP—JNK inhibitor SP600125 (20 μM); 20 h of treatment.

Journal: ACS Omega

Article Title: The Role and Efficacy of JNK Inhibition in Inducing Lung Cancer Cell Death Depend on the Concentration of Cisplatin

doi: 10.1021/acsomega.4c01950

Figure Lengend Snippet: Opposite changes in TP53 and AKT phosphorylation following SP600125 treatment of A549 cells exposed to different concentrations of cisplatin. (a) Expression of TP53 is increased in response to the combination of SP + 7.5 μg/mL cisplatin, in contrast to the combination of SP + 30 μg/mL cisplatin. (b) Phosphorylation of TP53 (serine-6) is increased in response to the combination of SP + 7.5 μg/mL cisplatin, in contrast to the combination of SP + 30 μg/mL cisplatin. (c) Phosphorylation of AKT (threonine-308) is decreased in response to the combination of SP + 7.5 μg/mL cisplatin, in contrast to the combination of SP + 30 μg/mL cisplatin. Representative Western blots are shown. Total protein Coomassie-stained polyacrylamide gels serve as a loading control. SP—JNK inhibitor SP600125 (20 μM); 20 h of treatment.

Article Snippet: Human non-small-cell lung carcinoma A549 cells were purchased from Cell Lines Service GmbH, Eppelheim, Germany.

Techniques: Phospho-proteomics, Expressing, Western Blot, Staining, Control

FIGURE 2. High glucose promoted PKA-dependent phosphorylation of Hsp90. A, Hsp90 was immunoprecipitated (IP) with an anti-Hsp90 anti- body from total lysates (using 1 107 cells/sample) as described under “Experimental Procedures.” Immunoprecipitates were prepared in parallel with non-immune IgG. The resulting samples were subjected to a phos- phospecific PKA substrate Western blot (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). The ratio of the signal from the bottom and top panels is presented. The results show that there was 2.3-fold more phosphorylated Hsp90 in samples prepared from the HG- treated cells as compared with those cultured in normal glucose. In three independent experiments, the fold difference was 2.2 0.2. B, same as A except the HG-treated cells were exposed to the PKA inhibitor PKI (0.5 mol/ liter) for 12 h prior to lysis. The PKI treatment reduced the amount of Hsp90 recognizedbythephospho-PKAsubstrateantibodyby2.6-fold.Inthreeinde- pendent experiments, the average fold difference was 2.7 0.2.

Journal: The Journal of biological chemistry

Article Title: Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes.

doi: 10.1074/jbc.M608985200

Figure Lengend Snippet: FIGURE 2. High glucose promoted PKA-dependent phosphorylation of Hsp90. A, Hsp90 was immunoprecipitated (IP) with an anti-Hsp90 anti- body from total lysates (using 1 107 cells/sample) as described under “Experimental Procedures.” Immunoprecipitates were prepared in parallel with non-immune IgG. The resulting samples were subjected to a phos- phospecific PKA substrate Western blot (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). The ratio of the signal from the bottom and top panels is presented. The results show that there was 2.3-fold more phosphorylated Hsp90 in samples prepared from the HG- treated cells as compared with those cultured in normal glucose. In three independent experiments, the fold difference was 2.2 0.2. B, same as A except the HG-treated cells were exposed to the PKA inhibitor PKI (0.5 mol/ liter) for 12 h prior to lysis. The PKI treatment reduced the amount of Hsp90 recognizedbythephospho-PKAsubstrateantibodyby2.6-fold.Inthreeinde- pendent experiments, the average fold difference was 2.7 0.2.

Article Snippet: The following antibodies were obtained from commercial sources: phospho-(Ser/Thr) PKA substrate antibody (number 9621, Cell Signaling Technology, Beverly, MA); anti-FLAG M2 monoclonal antibody (Sigma), and anti-eNOS mouse monoclonal antibody (BD Transduction Laboratories); goat anti-Hsp90 polyclonal antibody and non-immune goat IgG (Santa Cruz Biotechnology); horseradish peroxidase-conjugated goat antirabbit antibodies (AmershamBiosciences); and fluorescein isothiocyante-conjugated AffiniPure sheep anti-goat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA).

Techniques: Phospho-proteomics, Immunoprecipitation, Western Blot, Membrane, Cell Culture, Lysis

FIGURE 4. Phosphorylated Hsp90 was predominately on the cell sur- face. PAECs were treated with HG (30 mmol/liter) for 2 weeks. Hsp90 was immunoprecipitated (IP) with an anti-Hsp90 antibody from the cell surface (using 3 107 cells/sample) or from total lysates (using 0.5 107 cells/sam- ple) as described under “Experimental Procedures.” Immunoprecipitates were prepared in parallel with non-immune IgG. The resulting samples were subjected to a phosphospecific PKA substrate Western blot (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). Theratioofthesignalfromthebottomandtoppanelsispresented.Theresults showed that there was 13.6-fold more phosphorylated Hsp90 in samples prepared from the cell surface as compared with total cell lysates. In three independent experiments, the average -fold difference was 11.8 1.5.

Journal: The Journal of biological chemistry

Article Title: Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes.

doi: 10.1074/jbc.M608985200

Figure Lengend Snippet: FIGURE 4. Phosphorylated Hsp90 was predominately on the cell sur- face. PAECs were treated with HG (30 mmol/liter) for 2 weeks. Hsp90 was immunoprecipitated (IP) with an anti-Hsp90 antibody from the cell surface (using 3 107 cells/sample) or from total lysates (using 0.5 107 cells/sam- ple) as described under “Experimental Procedures.” Immunoprecipitates were prepared in parallel with non-immune IgG. The resulting samples were subjected to a phosphospecific PKA substrate Western blot (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). Theratioofthesignalfromthebottomandtoppanelsispresented.Theresults showed that there was 13.6-fold more phosphorylated Hsp90 in samples prepared from the cell surface as compared with total cell lysates. In three independent experiments, the average -fold difference was 11.8 1.5.

Article Snippet: The following antibodies were obtained from commercial sources: phospho-(Ser/Thr) PKA substrate antibody (number 9621, Cell Signaling Technology, Beverly, MA); anti-FLAG M2 monoclonal antibody (Sigma), and anti-eNOS mouse monoclonal antibody (BD Transduction Laboratories); goat anti-Hsp90 polyclonal antibody and non-immune goat IgG (Santa Cruz Biotechnology); horseradish peroxidase-conjugated goat antirabbit antibodies (AmershamBiosciences); and fluorescein isothiocyante-conjugated AffiniPure sheep anti-goat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA).

Techniques: Immunoprecipitation, Western Blot, Membrane

FIGURE 8. DM increased phosphorylation of Hsp90 at a PKA consen- sus site and decreased the Hsp90eNOS complex. A, lysates prepared from the aortic endothelium of five diabetic or age-matched control rats were pooled, and analyzed by Western blotting using a phosphospecific PKA substrate antibody (top panel) and a RasGAP antibody (lower panel). B, the lysates described in A were immunoprecipitated (IP) with a Hsp90 antibody or non-immune IgG, and the resulting samples were analyzed by Western blot using a phosphospecific PKA substrate antibody (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). Quantification of Western blots showed a 2.2 0.2-fold increase in the amount of phospho-Hsp90 in the diabetic endothelium in three independent experiments. C, the Western blot described in B was reprobed using an anti-eNOS antibody. DM reduced the association of eNOS with Hsp90 in the endothelium of the diabetic rat aorta by 2.4 0.2-fold com- pared with the controls. The differences in panels B and C were statistically significant.

Journal: The Journal of biological chemistry

Article Title: Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes.

doi: 10.1074/jbc.M608985200

Figure Lengend Snippet: FIGURE 8. DM increased phosphorylation of Hsp90 at a PKA consen- sus site and decreased the Hsp90eNOS complex. A, lysates prepared from the aortic endothelium of five diabetic or age-matched control rats were pooled, and analyzed by Western blotting using a phosphospecific PKA substrate antibody (top panel) and a RasGAP antibody (lower panel). B, the lysates described in A were immunoprecipitated (IP) with a Hsp90 antibody or non-immune IgG, and the resulting samples were analyzed by Western blot using a phosphospecific PKA substrate antibody (top panel). The stripped membrane was reprobed with a Hsp90 antibody (bottom panel). Quantification of Western blots showed a 2.2 0.2-fold increase in the amount of phospho-Hsp90 in the diabetic endothelium in three independent experiments. C, the Western blot described in B was reprobed using an anti-eNOS antibody. DM reduced the association of eNOS with Hsp90 in the endothelium of the diabetic rat aorta by 2.4 0.2-fold com- pared with the controls. The differences in panels B and C were statistically significant.

Article Snippet: The following antibodies were obtained from commercial sources: phospho-(Ser/Thr) PKA substrate antibody (number 9621, Cell Signaling Technology, Beverly, MA); anti-FLAG M2 monoclonal antibody (Sigma), and anti-eNOS mouse monoclonal antibody (BD Transduction Laboratories); goat anti-Hsp90 polyclonal antibody and non-immune goat IgG (Santa Cruz Biotechnology); horseradish peroxidase-conjugated goat antirabbit antibodies (AmershamBiosciences); and fluorescein isothiocyante-conjugated AffiniPure sheep anti-goat IgG (Jackson ImmunoResearch Laboratories, West Grove, PA).

Techniques: Phospho-proteomics, Control, Western Blot, Immunoprecipitation, Membrane

Figure 1. Dose- and time-dependent inhibition of bladder cancer cell migration by hAM preparations. (A–E′) Representative images of wound healing of T24 cells. (F–J′) Representative images of wound healing of RT4 cells. (K–O′) Representative images of wound healing of NPU cells. (P-R) Percentage of wound healing of T24, RT4 and NPU cells, respectively. Data are presented as mean ± standard error of the mean (SEM) of at least three independent experiments. *P < 0.05 vs. control group. Scale bars 50 µm.

Journal: Scientific reports

Article Title: Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway.

doi: 10.1038/s41598-023-46091-2

Figure Lengend Snippet: Figure 1. Dose- and time-dependent inhibition of bladder cancer cell migration by hAM preparations. (A–E′) Representative images of wound healing of T24 cells. (F–J′) Representative images of wound healing of RT4 cells. (K–O′) Representative images of wound healing of NPU cells. (P-R) Percentage of wound healing of T24, RT4 and NPU cells, respectively. Data are presented as mean ± standard error of the mean (SEM) of at least three independent experiments. *P < 0.05 vs. control group. Scale bars 50 µm.

Article Snippet: Normal and cancer urothelial models Human muscle-invasive bladder cancer T24 cells and human non-invasive transitional cell papilloma RT4 cells were purchased from the American Type Culture Collection (ATCC) and grown in culture medium consisting of equal parts A-DMEM (Gibco, Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) and F12 (Sigma-Aldrich, Merck, Darmstadt, Germany), 5% foetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA) and 4 mM glutamax (Gibco, Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Inhibition, Migration, Control

Figure 3. hAM homogenate and extract suppress the migration rate of non-invasive urothelial papilloma RT4 cells by decreasing the amount of lamellipodia and filopodia along the leading edge. RT4 cells treated with hAM homogenate, hAM extract or an appropriate culture medium (control) migrate collectively and maintain an epithelial morphology. However, migrating RT4 cells, treated with hAM preparations, contain less lamellipodia and filopodia (red arrows) along the leading edge than untreated control RT4 cells. Larger framed inset with black lines are the enlarged images of the corresponding smaller framed inserts. The presented images were acquired consecutively every 3 h and 15 min (shown in seconds) after the treatment. Shown is one representative experiment out of three independent experiments with different hAM preparations. Scale bars 50 µm.

Journal: Scientific reports

Article Title: Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway.

doi: 10.1038/s41598-023-46091-2

Figure Lengend Snippet: Figure 3. hAM homogenate and extract suppress the migration rate of non-invasive urothelial papilloma RT4 cells by decreasing the amount of lamellipodia and filopodia along the leading edge. RT4 cells treated with hAM homogenate, hAM extract or an appropriate culture medium (control) migrate collectively and maintain an epithelial morphology. However, migrating RT4 cells, treated with hAM preparations, contain less lamellipodia and filopodia (red arrows) along the leading edge than untreated control RT4 cells. Larger framed inset with black lines are the enlarged images of the corresponding smaller framed inserts. The presented images were acquired consecutively every 3 h and 15 min (shown in seconds) after the treatment. Shown is one representative experiment out of three independent experiments with different hAM preparations. Scale bars 50 µm.

Article Snippet: Normal and cancer urothelial models Human muscle-invasive bladder cancer T24 cells and human non-invasive transitional cell papilloma RT4 cells were purchased from the American Type Culture Collection (ATCC) and grown in culture medium consisting of equal parts A-DMEM (Gibco, Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) and F12 (Sigma-Aldrich, Merck, Darmstadt, Germany), 5% foetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA) and 4 mM glutamax (Gibco, Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Migration, Control

Figure 6. hAM homogenate and extract down-regulate FAK expression in bladder cancer urothelial cells but not in normal urothelial cells. (A) Western blot analysis of FAK and p-FAK in T24, RT4 and NPU cells treated for 24 h with hAM homogenate, hAM extract or appropriate culture medium (control samples) without hAM preparations. (A′) The expression and phosphorylation of FAK were normalised to the level of α-tubulin. In addition, the expression and phosphorylation of FAK in the treated samples were normalised to the control samples and these values are presented as log2 fold change (log2FC). The results are expressed as median (solid black line) with data range (minimum and maximum). The dashed black lines represent the normalised value of the control sample (0). The results were obtained on the basis of 3–6 biological replicates. The most representative blot of the mean effect is presented. The original blots are presented in Supplementary Fig. 2. The absence of full-length membranes is due to the cropping of the membranes prior to hybridization with primary antibodies. * p ≤ 0.05. (B) qPCR analysis of PTK2 expression in T24, RT4 and NPU cells treated for 24 h with hAM homogenate, hAM extract or appropriate culture medium without hAM preparations (control samples). PTK2 expression was normalised to GAPDH levels. The qPCR results were presented as ΔCt (CtGAPDH − CtPTK2). Each dot in the graph represents the value of one biological sample. The solid red lines show the median and the solid black lines represent the interquartile range. *p ≤ 0.05.

Journal: Scientific reports

Article Title: Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway.

doi: 10.1038/s41598-023-46091-2

Figure Lengend Snippet: Figure 6. hAM homogenate and extract down-regulate FAK expression in bladder cancer urothelial cells but not in normal urothelial cells. (A) Western blot analysis of FAK and p-FAK in T24, RT4 and NPU cells treated for 24 h with hAM homogenate, hAM extract or appropriate culture medium (control samples) without hAM preparations. (A′) The expression and phosphorylation of FAK were normalised to the level of α-tubulin. In addition, the expression and phosphorylation of FAK in the treated samples were normalised to the control samples and these values are presented as log2 fold change (log2FC). The results are expressed as median (solid black line) with data range (minimum and maximum). The dashed black lines represent the normalised value of the control sample (0). The results were obtained on the basis of 3–6 biological replicates. The most representative blot of the mean effect is presented. The original blots are presented in Supplementary Fig. 2. The absence of full-length membranes is due to the cropping of the membranes prior to hybridization with primary antibodies. * p ≤ 0.05. (B) qPCR analysis of PTK2 expression in T24, RT4 and NPU cells treated for 24 h with hAM homogenate, hAM extract or appropriate culture medium without hAM preparations (control samples). PTK2 expression was normalised to GAPDH levels. The qPCR results were presented as ΔCt (CtGAPDH − CtPTK2). Each dot in the graph represents the value of one biological sample. The solid red lines show the median and the solid black lines represent the interquartile range. *p ≤ 0.05.

Article Snippet: Normal and cancer urothelial models Human muscle-invasive bladder cancer T24 cells and human non-invasive transitional cell papilloma RT4 cells were purchased from the American Type Culture Collection (ATCC) and grown in culture medium consisting of equal parts A-DMEM (Gibco, Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) and F12 (Sigma-Aldrich, Merck, Darmstadt, Germany), 5% foetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA) and 4 mM glutamax (Gibco, Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Expressing, Western Blot, Control, Phospho-proteomics, Hybridization

Figure 8. hAM homogenate inhibits the expression of proteins involved in actin cytoskeleton reorganisation. (A) Western blot analysis of cortactin, RhoA, RhoC, Cdc42, Rac1/2/3 and phosphorylation of cortactin in T24, RT4 and NPU cells treated for 24 h with hAM homogenate, hAM extract or appropriate culture medium (controls) without hAM preparations. (B–D) Quantification of relative protein expression and phosphorylation. The expression and phosphorylation of the target proteins were normalised to the α-tubulin values. In addition, the expression and phosphorylation of the target proteins in the treated samples were normalised to the control samples (culture medium without hAM preparation) and these values were presented as log2 fold change (log2FC). The results are as median (solid red line) with data range (minimum and maximum). The dashed black lines represent the normalised value of the control sample (0). Results were obtained on the basis of 3–6 biological replicates. The most representative blot of the mean effect is presented. The original blots are presented in Supplementary Fig. 2. The absence of full-length membranes is due to the cropping of the membranes prior to hybridization with primary antibodies. *p ≤ 0.05.

Journal: Scientific reports

Article Title: Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway.

doi: 10.1038/s41598-023-46091-2

Figure Lengend Snippet: Figure 8. hAM homogenate inhibits the expression of proteins involved in actin cytoskeleton reorganisation. (A) Western blot analysis of cortactin, RhoA, RhoC, Cdc42, Rac1/2/3 and phosphorylation of cortactin in T24, RT4 and NPU cells treated for 24 h with hAM homogenate, hAM extract or appropriate culture medium (controls) without hAM preparations. (B–D) Quantification of relative protein expression and phosphorylation. The expression and phosphorylation of the target proteins were normalised to the α-tubulin values. In addition, the expression and phosphorylation of the target proteins in the treated samples were normalised to the control samples (culture medium without hAM preparation) and these values were presented as log2 fold change (log2FC). The results are as median (solid red line) with data range (minimum and maximum). The dashed black lines represent the normalised value of the control sample (0). Results were obtained on the basis of 3–6 biological replicates. The most representative blot of the mean effect is presented. The original blots are presented in Supplementary Fig. 2. The absence of full-length membranes is due to the cropping of the membranes prior to hybridization with primary antibodies. *p ≤ 0.05.

Article Snippet: Normal and cancer urothelial models Human muscle-invasive bladder cancer T24 cells and human non-invasive transitional cell papilloma RT4 cells were purchased from the American Type Culture Collection (ATCC) and grown in culture medium consisting of equal parts A-DMEM (Gibco, Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) and F12 (Sigma-Aldrich, Merck, Darmstadt, Germany), 5% foetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA) and 4 mM glutamax (Gibco, Thermo Fisher Scientific, Waltham, MA, USA).

Techniques: Expressing, Western Blot, Phospho-proteomics, Control, Hybridization

Up, lung cancer cell lines of (A) A549, (B) HCC827, and (C) H1975 were administered with juglanin at different concentrations, ranging from 0 μM to 80 μM for 24 h. Then the cell viability was measured via MTT analysis. And the lung normal cell (D) MRC-5 was also treated with various concentrations of juglanin as indicated for 24 h. Then, MTT assays were conducted to calculate cell viability. Down, the lung cancer cell lines of (A) A549, (B) HCC827, and (C) H1975, and the lung normal cell of MRC-5 were treated with the presented concentrations of juglanin for 48 h, followed by MTT assays. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group without any treatment. (E) A549 and H1975 cells were cultured with 40 μM juglanin for 24 h. Then, flow cytometry assay was conducted to assess DNA contents in the sub-G1 phase. Con: the control group without any treatments. The representative images were exhibited. The quantification of the apoptotic (F) A549 and (G) H1975 cells in sub-G1 phase was calculated through statistic analysis. A549 and H1975 cells were treated with juglanin (10, 20 and 40 μM) for 24 h. The DNA fragmentation assay was conducted to determine DNA fragmentation in (H) A549 and (I) H1975 cells. (J) The representative images of apoptotic morphology of cancer cells treated with or without 40 μM juglanin for 24 h were shown. And the number of apoptotic cells per field was quantified. (K) Transmission electron microscopy was used to observe the chromatin condensation and the apoptotic cells after 40 μM juglanin treatment for 24 h. (L) The representative image of lung cancer cells experiencing apoptosis was displayed. The quantification of (M) A549 and (N) H1975 cells in apoptosis was assessed. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: Up, lung cancer cell lines of (A) A549, (B) HCC827, and (C) H1975 were administered with juglanin at different concentrations, ranging from 0 μM to 80 μM for 24 h. Then the cell viability was measured via MTT analysis. And the lung normal cell (D) MRC-5 was also treated with various concentrations of juglanin as indicated for 24 h. Then, MTT assays were conducted to calculate cell viability. Down, the lung cancer cell lines of (A) A549, (B) HCC827, and (C) H1975, and the lung normal cell of MRC-5 were treated with the presented concentrations of juglanin for 48 h, followed by MTT assays. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group without any treatment. (E) A549 and H1975 cells were cultured with 40 μM juglanin for 24 h. Then, flow cytometry assay was conducted to assess DNA contents in the sub-G1 phase. Con: the control group without any treatments. The representative images were exhibited. The quantification of the apoptotic (F) A549 and (G) H1975 cells in sub-G1 phase was calculated through statistic analysis. A549 and H1975 cells were treated with juglanin (10, 20 and 40 μM) for 24 h. The DNA fragmentation assay was conducted to determine DNA fragmentation in (H) A549 and (I) H1975 cells. (J) The representative images of apoptotic morphology of cancer cells treated with or without 40 μM juglanin for 24 h were shown. And the number of apoptotic cells per field was quantified. (K) Transmission electron microscopy was used to observe the chromatin condensation and the apoptotic cells after 40 μM juglanin treatment for 24 h. (L) The representative image of lung cancer cells experiencing apoptosis was displayed. The quantification of (M) A549 and (N) H1975 cells in apoptosis was assessed. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Control, Cell Culture, Flow Cytometry, DNA Fragmentation Assay, Transmission Assay, Electron Microscopy

(A) A549 and H1975 cells were given juglanin at 0, 20, 30 and 40 μM for 24 h. Then, the cell protein was extracted and subjected to immunoblotting analysis for Caspase-8, Caspase-9, Caspase-3 and PARP determination. The quantification of western blot results of (B) A549 and (C) H1975 was shown. (D) Bcl-2 family, including Bcl-2, Bcl-xl, Bax and Bad, protein levels in A549 and H1975 cells after treatment under various conditions were evaluated by western blot analysis. The western blotting results in (E) A549 and (F) H1975 cells were quantified. (G) A549 and (H) H1975 lung cancer cells were treated with different concentrations of juglanin without Caspase-3 and Caspase-9 inhibitors of Z-DEVD-FMK and Z-LEHD-FMK for 24 h. Then cleaved Caspase-3 and Caspase-9 activity was calculated. (I) A549 and (J) H1975 cells were administered with the indicated concentrations of juglanin in the presence of Z-DEVD-FMK and Z-LEHD-FMK for 24 h, followed by determination of Caspase-3 and Caspase-9 cleavage. The cell viability of (K) A549 and (L) H1975 cells after Caspases inhibitors treatment was assessed by the use of MTT assay. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. ++ P < 0.01 and +++ P < 0.001 compared to 20 μM juglanin treatment without Caspases inhibitors. ## P < 0.01 compared to 30 μM juglanin treatment without Caspases inhibitors. !!! P < 0.001 compared to 40 μM juglanin treatment without Caspases inhibitors.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: (A) A549 and H1975 cells were given juglanin at 0, 20, 30 and 40 μM for 24 h. Then, the cell protein was extracted and subjected to immunoblotting analysis for Caspase-8, Caspase-9, Caspase-3 and PARP determination. The quantification of western blot results of (B) A549 and (C) H1975 was shown. (D) Bcl-2 family, including Bcl-2, Bcl-xl, Bax and Bad, protein levels in A549 and H1975 cells after treatment under various conditions were evaluated by western blot analysis. The western blotting results in (E) A549 and (F) H1975 cells were quantified. (G) A549 and (H) H1975 lung cancer cells were treated with different concentrations of juglanin without Caspase-3 and Caspase-9 inhibitors of Z-DEVD-FMK and Z-LEHD-FMK for 24 h. Then cleaved Caspase-3 and Caspase-9 activity was calculated. (I) A549 and (J) H1975 cells were administered with the indicated concentrations of juglanin in the presence of Z-DEVD-FMK and Z-LEHD-FMK for 24 h, followed by determination of Caspase-3 and Caspase-9 cleavage. The cell viability of (K) A549 and (L) H1975 cells after Caspases inhibitors treatment was assessed by the use of MTT assay. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. ++ P < 0.01 and +++ P < 0.001 compared to 20 μM juglanin treatment without Caspases inhibitors. ## P < 0.01 compared to 30 μM juglanin treatment without Caspases inhibitors. !!! P < 0.001 compared to 40 μM juglanin treatment without Caspases inhibitors.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Western Blot, Activity Assay, MTT Assay, Control

A549 and H1975 cells were exposed to various concentrations of juglanin for 24 h. RT-qPCR analysis was conducted to calculate the mRNA levels of TRAIL, DR4, DR5 and FADD in (A) A549 and (B) H1975 cells. (C) Up, representative images of c-Abl, p73 and p53 detected by western blot analysis were shown in both A549 and H1975 cells. Down, the quantification of c-Abl, p73 and p53 protein levels following the immunoblotting assays. (D) Left, A549 and H1975 cells were treated with 40 μM juglanin for the indicated time. Then, the p53 protein levels were calculated by the use of specific antibody. Right, the quantification of the immunoblotting data was shown. (E) A549 and (F) H1975 cells were treated with 40 μM juglanin in the presence or absence of different concentrations (0, 10, 20, 30 and 40 μM) of p53 inhibitor PFT-α for 24 h, followed by RT-qPCR analysis to detect TRAIL, DR4, DR5 and FADD mRNA levels. (G) Up, A549 and H1975 cells were treated with juglanin (40 μM) and various concentrations, ranged from 0 to 40 μM, of p53 inhibitor PFT-α for 24 h. Next, western blot assays were used to determine TRAIL, DR4, DR5 and FADD protein levels. Down, the quantification of immunoblotting data was exhibited. (H) A549 and H1975 cells were treated with 40 μM juglanin with or without PFT-α (40 μM) for 24 h ahead of flow cytometry analysis to assess apoptotic cells. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: A549 and H1975 cells were exposed to various concentrations of juglanin for 24 h. RT-qPCR analysis was conducted to calculate the mRNA levels of TRAIL, DR4, DR5 and FADD in (A) A549 and (B) H1975 cells. (C) Up, representative images of c-Abl, p73 and p53 detected by western blot analysis were shown in both A549 and H1975 cells. Down, the quantification of c-Abl, p73 and p53 protein levels following the immunoblotting assays. (D) Left, A549 and H1975 cells were treated with 40 μM juglanin for the indicated time. Then, the p53 protein levels were calculated by the use of specific antibody. Right, the quantification of the immunoblotting data was shown. (E) A549 and (F) H1975 cells were treated with 40 μM juglanin in the presence or absence of different concentrations (0, 10, 20, 30 and 40 μM) of p53 inhibitor PFT-α for 24 h, followed by RT-qPCR analysis to detect TRAIL, DR4, DR5 and FADD mRNA levels. (G) Up, A549 and H1975 cells were treated with juglanin (40 μM) and various concentrations, ranged from 0 to 40 μM, of p53 inhibitor PFT-α for 24 h. Next, western blot assays were used to determine TRAIL, DR4, DR5 and FADD protein levels. Down, the quantification of immunoblotting data was exhibited. (H) A549 and H1975 cells were treated with 40 μM juglanin with or without PFT-α (40 μM) for 24 h ahead of flow cytometry analysis to assess apoptotic cells. The data are presented as mean ± S.E.M. of three independent experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Quantitative RT-PCR, Western Blot, Flow Cytometry, Control

(A) A549 and H1975 cells were treated with different concentrations of juglanin as indicated for 24 h. Then, the nuclues protein was extracted for western blot analysis of NF-κB by the specifc antibody. And Lamin B was applied as the loading control. (B) Total cell extracts were used to detect IκBα and phosphorylated IκBα protein levels. (C) A549 and H1975 cells were administered with different concentrations of juglanin for 24 h, followed by the whole cell protein extracts to calculate p-PI3K and p-AKT levels through western blot assays. (D) The flow cytometry analysis was used to determine apoptotic cells. A549 and HCC 827 cells were treated with 40 μM juglanin with or without PI3K/AKT inhibitor LY294002 (5 μM) for 24 h. (E) A549 and H1975 cells were treated with the indicated concentrations of juglanin for 24 h. And western blotting analysis was conducted to determine p-p38, p-ERK1/2 and p-JNK levels. The representative images were shown. The quantification of the immunoblotting results in (F) A549 and (G) H1975 cells. (H) A549 and HCC 827 cells were treated with 40 μM juglanin in the presence or absence of p38 activator p79350 (5 μM) for 24 h. The flow cytometry analysis was performed to detect apoptotic cells. (I) A549 and HCC 827 cells were exposed to 40 μM juglanin with or without ERK1/2 inhibitor 5 μM PD98059 for 24 h. The flow cytometry assay was used to determine apoptotic cells. (J) A549 and HCC 827 cells were treated by the use of 40 μM juglanin with or without JNK activator Anisomycin (5 μM) for 24 h. Apoptotic cells were determined by flow cytometry. The data are presented as mean ± S.E.M. of three separate experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. + P < 0.05 and ++ P < 0.01 were considered with significant difference.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: (A) A549 and H1975 cells were treated with different concentrations of juglanin as indicated for 24 h. Then, the nuclues protein was extracted for western blot analysis of NF-κB by the specifc antibody. And Lamin B was applied as the loading control. (B) Total cell extracts were used to detect IκBα and phosphorylated IκBα protein levels. (C) A549 and H1975 cells were administered with different concentrations of juglanin for 24 h, followed by the whole cell protein extracts to calculate p-PI3K and p-AKT levels through western blot assays. (D) The flow cytometry analysis was used to determine apoptotic cells. A549 and HCC 827 cells were treated with 40 μM juglanin with or without PI3K/AKT inhibitor LY294002 (5 μM) for 24 h. (E) A549 and H1975 cells were treated with the indicated concentrations of juglanin for 24 h. And western blotting analysis was conducted to determine p-p38, p-ERK1/2 and p-JNK levels. The representative images were shown. The quantification of the immunoblotting results in (F) A549 and (G) H1975 cells. (H) A549 and HCC 827 cells were treated with 40 μM juglanin in the presence or absence of p38 activator p79350 (5 μM) for 24 h. The flow cytometry analysis was performed to detect apoptotic cells. (I) A549 and HCC 827 cells were exposed to 40 μM juglanin with or without ERK1/2 inhibitor 5 μM PD98059 for 24 h. The flow cytometry assay was used to determine apoptotic cells. (J) A549 and HCC 827 cells were treated by the use of 40 μM juglanin with or without JNK activator Anisomycin (5 μM) for 24 h. Apoptotic cells were determined by flow cytometry. The data are presented as mean ± S.E.M. of three separate experiments performed in duplicate. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. + P < 0.05 and ++ P < 0.01 were considered with significant difference.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Western Blot, Control, Flow Cytometry

(A) A549 and H1975 cells were pre-treated with 40 μM juglanin for 24 h. Then, the ROS generation was calculated. The representative images were shown here. The quantification of ROS production in (B) A549 and (C) H1975 cells was represented as relative fluorescent intensity. (D) A549 and (E) H1975 cells were treated with 10 mM NAC (ROS scavenger) for 2 h, and 40 μM juglanin for 24 h, or the combination of NAC for 2 h during exposure to juglanin for 24 h. Then, the cell viability was determined by MTT analysis. (F) A549 and (G) H1975 cells were administered with 10 mM NAC for 2 h, and 40 μM juglanin for 24 h, or NAC for 2 h during juglanin treatment for 24 h, followed by apoptotic cells determination through flow cytometry assay. The data are presented as mean ± S.E.M. of three separate experiments performed in duplicate. ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. + P < 0.05, ++ P < 0.01 and +++ P < 0.001 were considered with significant difference. n.s. referred to no significant difference.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: (A) A549 and H1975 cells were pre-treated with 40 μM juglanin for 24 h. Then, the ROS generation was calculated. The representative images were shown here. The quantification of ROS production in (B) A549 and (C) H1975 cells was represented as relative fluorescent intensity. (D) A549 and (E) H1975 cells were treated with 10 mM NAC (ROS scavenger) for 2 h, and 40 μM juglanin for 24 h, or the combination of NAC for 2 h during exposure to juglanin for 24 h. Then, the cell viability was determined by MTT analysis. (F) A549 and (G) H1975 cells were administered with 10 mM NAC for 2 h, and 40 μM juglanin for 24 h, or NAC for 2 h during juglanin treatment for 24 h, followed by apoptotic cells determination through flow cytometry assay. The data are presented as mean ± S.E.M. of three separate experiments performed in duplicate. ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. + P < 0.05, ++ P < 0.01 and +++ P < 0.001 were considered with significant difference. n.s. referred to no significant difference.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Flow Cytometry, Control

(A) A549 and H1975 cells were treated with 40 μM juglanin for 24 h. Next, the acidic vacuoles formation was analyzed by Acridine Orange (AO) staining (Left). And LC3-GFP puncta was used to analyze the autophagy condition of lung cancer cells treated as indicated (Right). (B) A549 and H1975 cells were administrated with various concentrations of jugalnin for 24 h. And western blot analysis was used to calculate LC3I/II, ATG7 and ATG3 protein levels. The quantification of the immunoblotting data from (C) A549 and (D) H1975 was shown. (E) The protein expression levels of autophagy induction-related signals, including Beclin1, and PIK3C3 were calculated through western blot analysis. And the quantification of these signals in (F) A549 and (G) H1975 cells was displayed. (H) ATG7 was knockdown in A549 cells treated with or without juglanin at 40 μM. Then, western blot analysis was used to evaluate ATG7 and LC3I/II levels. (I) The quantification of ATG7 and LC3 following immunoblotting in A549 cells was displayed. (J) ATG7 was silenced in H1975 cells treated with or without 40 μM juglanin. Then, western blot analysis was performed to determine ATG7 and LC3I/II levels. (K) The quantification of ATG7 and LC3 according to the immunoblotting in H1975 cells was shown. The data are presented as mean ± S.E.M. of three separate experiments performed in duplicate. ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. + P < 0.05, ++ P < 0.01 and +++ P < 0.001 were considered with significant difference.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: (A) A549 and H1975 cells were treated with 40 μM juglanin for 24 h. Next, the acidic vacuoles formation was analyzed by Acridine Orange (AO) staining (Left). And LC3-GFP puncta was used to analyze the autophagy condition of lung cancer cells treated as indicated (Right). (B) A549 and H1975 cells were administrated with various concentrations of jugalnin for 24 h. And western blot analysis was used to calculate LC3I/II, ATG7 and ATG3 protein levels. The quantification of the immunoblotting data from (C) A549 and (D) H1975 was shown. (E) The protein expression levels of autophagy induction-related signals, including Beclin1, and PIK3C3 were calculated through western blot analysis. And the quantification of these signals in (F) A549 and (G) H1975 cells was displayed. (H) ATG7 was knockdown in A549 cells treated with or without juglanin at 40 μM. Then, western blot analysis was used to evaluate ATG7 and LC3I/II levels. (I) The quantification of ATG7 and LC3 following immunoblotting in A549 cells was displayed. (J) ATG7 was silenced in H1975 cells treated with or without 40 μM juglanin. Then, western blot analysis was performed to determine ATG7 and LC3I/II levels. (K) The quantification of ATG7 and LC3 according to the immunoblotting in H1975 cells was shown. The data are presented as mean ± S.E.M. of three separate experiments performed in duplicate. ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment. + P < 0.05, ++ P < 0.01 and +++ P < 0.001 were considered with significant difference.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Staining, Western Blot, Expressing, Knockdown, Control

The lung cancer cell A549 was subcutaneously injected into the dorsal flanks of 40 athymic nude mice. When the size of tumor reached to about 50 mm , the experimental animals were i.p. with 0, 10, 20 and 30 mg/kg juglanin each day for consecutive 4 weeks. (A) The tumor volume was measured every two days. (B) At the end of the in vivo study, the tumor from each group was weighed. (C) The body weight of the nude mice was analyzed. (D) At the end of the study, the liver from each mouse was obtained and weighed. (E) 24 athymic nude mice athymic nude mice were only treated with juglanin under different conditions (0, 10, 20 and 30 mg/kg) for consecutive 4 weeks. Finally, the representative images of liver, renal and lung sections analyzed by H&E staining were shown. (F) Liver normal cells L02 and (G) renal normal cells HK2 were treated with different concentrations (0,1.25, 2.5, 5, 10, 20, 40 and 80 μM) of juglanin for 24 h. Then, the cell viability was calculated through MTT assays. (H) The analysis of tumor tissue samples KI-67, autophagy (LC3B) and apoptosis (TUNEL) after treatment with juglanin under different conditions. The quota of tumor KI-67 positive cells, autophagy levels and apoptosis. The ratio of different positive cells was calculated from three fields with the highest density of positive-expressed cells in every section form each group. (I) Western blot analysis was used to calculate Caspase-3, PARP, Bcl-2 and Bax protein levels in the tumor tissue samples obtained from the mice under different conditions. The quantification of these proteins was shown. (J) p53, p-NF-κB and p-IκBα protein levels were calculated through western blotting analysis. (K) RT-qPCR assays were carried out to determine p53, TRAIL, DR4, DR5 and FADD mRNA levels in tumor tissue specimens. (L) PI3K, AKT, p38 and ERK1/2 phosphorylation was assessed by western blotting analysis. (M) Beclin1, PIK3C3, LC3I/II and ATG7 protein expression levels were measured via immunoblotting analysis. (J) The quantification of Beclin1, PIK3C3, LC3I/II and ATG7. (N) Beclin1, PIK3C3, LC3I/II and ATG7 gene levels were evaluated by RT-qPCR analysis. The results are presented as mean ± S.E.M. n=10. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.

Journal: Oncotarget

Article Title: Juglanin inhibits lung cancer by regulation of apoptosis, ROS and autophagy induction

doi: 10.18632/oncotarget.21317

Figure Lengend Snippet: The lung cancer cell A549 was subcutaneously injected into the dorsal flanks of 40 athymic nude mice. When the size of tumor reached to about 50 mm , the experimental animals were i.p. with 0, 10, 20 and 30 mg/kg juglanin each day for consecutive 4 weeks. (A) The tumor volume was measured every two days. (B) At the end of the in vivo study, the tumor from each group was weighed. (C) The body weight of the nude mice was analyzed. (D) At the end of the study, the liver from each mouse was obtained and weighed. (E) 24 athymic nude mice athymic nude mice were only treated with juglanin under different conditions (0, 10, 20 and 30 mg/kg) for consecutive 4 weeks. Finally, the representative images of liver, renal and lung sections analyzed by H&E staining were shown. (F) Liver normal cells L02 and (G) renal normal cells HK2 were treated with different concentrations (0,1.25, 2.5, 5, 10, 20, 40 and 80 μM) of juglanin for 24 h. Then, the cell viability was calculated through MTT assays. (H) The analysis of tumor tissue samples KI-67, autophagy (LC3B) and apoptosis (TUNEL) after treatment with juglanin under different conditions. The quota of tumor KI-67 positive cells, autophagy levels and apoptosis. The ratio of different positive cells was calculated from three fields with the highest density of positive-expressed cells in every section form each group. (I) Western blot analysis was used to calculate Caspase-3, PARP, Bcl-2 and Bax protein levels in the tumor tissue samples obtained from the mice under different conditions. The quantification of these proteins was shown. (J) p53, p-NF-κB and p-IκBα protein levels were calculated through western blotting analysis. (K) RT-qPCR assays were carried out to determine p53, TRAIL, DR4, DR5 and FADD mRNA levels in tumor tissue specimens. (L) PI3K, AKT, p38 and ERK1/2 phosphorylation was assessed by western blotting analysis. (M) Beclin1, PIK3C3, LC3I/II and ATG7 protein expression levels were measured via immunoblotting analysis. (J) The quantification of Beclin1, PIK3C3, LC3I/II and ATG7. (N) Beclin1, PIK3C3, LC3I/II and ATG7 gene levels were evaluated by RT-qPCR analysis. The results are presented as mean ± S.E.M. n=10. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared to Control group (Con) without any treatment.

Article Snippet: The human non-small cell lung cancer cell line A549, HCC827 and H1975 were obtained from American Type Culture Collection (MD, USA).

Techniques: Injection, In Vivo, Staining, TUNEL Assay, Western Blot, Quantitative RT-PCR, Phospho-proteomics, Expressing, Control

Fig. 5. Kinetic of cellular uptake of CRISPR-Cas9 system encapsulated in ADGN peptides in cells. (A) Flow cytometry analysis of Cy5-lalelled ADGN peptides encapsulating Cas9 mRNA and Cy3-labelled Luc sgRNA interactions with A549 and 3 T3-L1 cells after different times of incubation at a peptide to RNA molar ratio of 20. (B) Quantification of the pourcentage of positive cells analyzed by flow cytometry. Data are means ± SD of three independent experiments with n = 10,000 events/experiment. (C) Internalization of ADGN peptides encapsulating Cas9 mRNA and Luc sgRNA was evaluated on live A549 cells at peptides to RNA molar ratio of 20. Cells were transfected with ADGN peptides labelled with cyanin5 (red color) complexed with Cas9 mRNA and cyanin3-labelled Luc RNA (green color). Cell Mask was used to stain the cells. The cellular uptake was monitored by confocal fluorescence microscopy 30 min and 60 min post-transfection (scale bar: 5 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications.

doi: 10.1016/j.jconrel.2024.11.008

Figure Lengend Snippet: Fig. 5. Kinetic of cellular uptake of CRISPR-Cas9 system encapsulated in ADGN peptides in cells. (A) Flow cytometry analysis of Cy5-lalelled ADGN peptides encapsulating Cas9 mRNA and Cy3-labelled Luc sgRNA interactions with A549 and 3 T3-L1 cells after different times of incubation at a peptide to RNA molar ratio of 20. (B) Quantification of the pourcentage of positive cells analyzed by flow cytometry. Data are means ± SD of three independent experiments with n = 10,000 events/experiment. (C) Internalization of ADGN peptides encapsulating Cas9 mRNA and Luc sgRNA was evaluated on live A549 cells at peptides to RNA molar ratio of 20. Cells were transfected with ADGN peptides labelled with cyanin5 (red color) complexed with Cas9 mRNA and cyanin3-labelled Luc RNA (green color). Cell Mask was used to stain the cells. The cellular uptake was monitored by confocal fluorescence microscopy 30 min and 60 min post-transfection (scale bar: 5 μm). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: Human non-small cell lung cancer A549 cells (ATCC® CCL-185TM) stably transfected with pGL3 firefly luc2 luciferase (A549-luc) and human breast cancer cell line MCF7 stably expressing luc2 luciferase (ATCC® HTB-22TM) were obtained from Optimal platform (IAB Grenoble, France).

Techniques: CRISPR, Flow Cytometry, Incubation, Transfection, Staining, Fluorescence, Microscopy

Fig. 6. Efficient in vitro luciferase downregulation in cells transfected with CRISPR-Cas9 delivered by ADGN peptides. Normalized luciferase activity in luciferase expressing A549 (A) or MCF7 cell lines (B) was compared after transfection of CRISPR-Cas9 RNA system targeting luciferase delivered by ADGN peptides at 2 different peptides to RNA molar ratios (20 or 10) that correspond to 1 or 0.5 μg RNA or by JetMESSENGER agent using 0.2 μg RNA (mean ± s.d., n = 3 biologically independent samples). Each error bar represents the SD of three independent quantitative PCR runs. *Indicates p < 0.05 between groups. **Indicates p < 0.01 vs. control vector unless otherwise labelled. A549 (C) and MCF7 (D) cell viability were determined for each conditions mentioned above using MTS test.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications.

doi: 10.1016/j.jconrel.2024.11.008

Figure Lengend Snippet: Fig. 6. Efficient in vitro luciferase downregulation in cells transfected with CRISPR-Cas9 delivered by ADGN peptides. Normalized luciferase activity in luciferase expressing A549 (A) or MCF7 cell lines (B) was compared after transfection of CRISPR-Cas9 RNA system targeting luciferase delivered by ADGN peptides at 2 different peptides to RNA molar ratios (20 or 10) that correspond to 1 or 0.5 μg RNA or by JetMESSENGER agent using 0.2 μg RNA (mean ± s.d., n = 3 biologically independent samples). Each error bar represents the SD of three independent quantitative PCR runs. *Indicates p < 0.05 between groups. **Indicates p < 0.01 vs. control vector unless otherwise labelled. A549 (C) and MCF7 (D) cell viability were determined for each conditions mentioned above using MTS test.

Article Snippet: Human non-small cell lung cancer A549 cells (ATCC® CCL-185TM) stably transfected with pGL3 firefly luc2 luciferase (A549-luc) and human breast cancer cell line MCF7 stably expressing luc2 luciferase (ATCC® HTB-22TM) were obtained from Optimal platform (IAB Grenoble, France).

Techniques: In Vitro, Luciferase, Transfection, CRISPR, Activity Assay, Expressing, Real-time Polymerase Chain Reaction, Control, Plasmid Preparation

Fig. 7. Efficient in vitro luciferase editing in A549 cells transfected with CRISPR-Cas9 delivered by ADGN peptides. (A) Representative results of T7-endonuclease I (T7E1) gel shift assays for the indels induced by CRISPR/Cas9 within luciferase gene. (B) Schematic representation of primers positions used for quantitative PCR (qPCR) based mutation detection using a wild type (WT) DNA specific primer pair called IN that directly binds to the expected site of mutation. The amplification curve shows that WT sequences can be amplified with optimal PCR efficiency (in grey), whereas amplification of mutated DNA is partially inhibited depending on the ratio of mutated to unmutated alleles. Relative quantification of luciferase gene by qPCR before and after incubation of A549 cells with CRISPR-Cas9 delivered by ADGN peptides with a peptides/RNA molar ratio of 20 or delivered by JetMESSENGER agent. (C) Gene sequence of the mutated luciferase gene at the DNA site targeted by CRISPRCas9 system in luciferase mutant single-cell. The number of deleted or inserted nucleotides is marked on the left of each sequence. sgRNA and PAM are shown on grey and yellow respectively. The expected cutting site is shown with a vertical dotted line. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications.

doi: 10.1016/j.jconrel.2024.11.008

Figure Lengend Snippet: Fig. 7. Efficient in vitro luciferase editing in A549 cells transfected with CRISPR-Cas9 delivered by ADGN peptides. (A) Representative results of T7-endonuclease I (T7E1) gel shift assays for the indels induced by CRISPR/Cas9 within luciferase gene. (B) Schematic representation of primers positions used for quantitative PCR (qPCR) based mutation detection using a wild type (WT) DNA specific primer pair called IN that directly binds to the expected site of mutation. The amplification curve shows that WT sequences can be amplified with optimal PCR efficiency (in grey), whereas amplification of mutated DNA is partially inhibited depending on the ratio of mutated to unmutated alleles. Relative quantification of luciferase gene by qPCR before and after incubation of A549 cells with CRISPR-Cas9 delivered by ADGN peptides with a peptides/RNA molar ratio of 20 or delivered by JetMESSENGER agent. (C) Gene sequence of the mutated luciferase gene at the DNA site targeted by CRISPRCas9 system in luciferase mutant single-cell. The number of deleted or inserted nucleotides is marked on the left of each sequence. sgRNA and PAM are shown on grey and yellow respectively. The expected cutting site is shown with a vertical dotted line. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: Human non-small cell lung cancer A549 cells (ATCC® CCL-185TM) stably transfected with pGL3 firefly luc2 luciferase (A549-luc) and human breast cancer cell line MCF7 stably expressing luc2 luciferase (ATCC® HTB-22TM) were obtained from Optimal platform (IAB Grenoble, France).

Techniques: In Vitro, Luciferase, Transfection, CRISPR, Gel Shift, Real-time Polymerase Chain Reaction, Mutagenesis, Amplification, Quantitative Proteomics, Incubation, Sequencing